<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_Dy7cezg">Pareto optimization to accelerate multi-objective virtual screening †</title>
				<funder ref="#_bXzbqaf">
					<orgName type="full">unknown</orgName>
				</funder>
				<funder ref="#_uPwmjmg">
					<orgName type="full">National Science Foundation Graduate Research Fellowship Program</orgName>
					<orgName type="abbreviated">GRFP</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100023581</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2024 The Author(s). Published by the Royal Society of Chemistry This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. 38 AM. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online © 2024 The Author(s). Published by the Royal Society of Chemistry 38 AM. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online Digital Discovery Paper 00:38 AM. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online © 2024 The Author(s). Published by the Royal Society of Chemistry 38 AM. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online © 2024 The Author(s). Published by the Royal Society of Chemistry 38 AM. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online © 2024 The Author(s). Published by the Royal Society of Chemistry This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. View Article Online</p>
				</availability>
				<date type="published" when="2024-01-15">15 January 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jenna</forename><forename type="middle">C</forename><surname>Fromer</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>a</label> Department of Chemical Engineering , MIT , Cambridge , MA 02139 , USA.</note>
								<orgName type="department">Department of Chemical Engineering</orgName>
								<orgName type="institution">MIT</orgName>
								<address>
									<postCode>02139</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">David</forename><forename type="middle">E</forename><surname>Graff</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Connor</forename><forename type="middle">W</forename><surname>Coley</surname></persName>
							<email>ccoley@mit.edu</email>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>b</label> Department of Chemistry and Chemical Biology , Harvard University , Cambridge , MA 02138 , USA</note>
								<orgName type="department">Department of Chemistry and Chemical Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>c</label> Department of Electrical Engineering and Computer Science , MIT , Cambridge , MA 02139 , USA</note>
								<orgName type="department">Department of Electrical Engineering and Computer Science</orgName>
								<orgName type="institution">MIT</orgName>
								<address>
									<postCode>02139</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_tAe8vY4">Pareto optimization to accelerate multi-objective virtual screening †</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2024-01-15">15 January 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">3479E33460EE87F7F258735B6AFD3288</idno>
					<idno type="DOI">10.1039/d3dd00227f</idno>
					<note type="submission">Received 20th November 2023 Accepted 14th January 2024</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T05:04+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_dqAJgQK"><p xml:id="_zw7kVa3"><s xml:id="_ujpMvu8">The discovery of therapeutic molecules is fundamentally a multi-objective optimization problem.</s><s xml:id="_hjWR5Yh">One formulation of the problem is to identify molecules that simultaneously exhibit strong binding affinity for a target protein, minimal off-target interactions, and suitable pharmacokinetic properties.</s><s xml:id="_KsBSssx">Inspired by prior work that uses active learning to accelerate the identification of strong binders, we implement multi-objective Bayesian optimization to reduce the computational cost of multi-property virtual screening and apply it to the identification of ligands predicted to be selective based on docking scores to on-and off-targets.</s><s xml:id="_936e3ZR">We demonstrate the superiority of Pareto optimization over scalarization across three case studies.</s><s xml:id="_FpjsXvR">Further, we use the developed optimization tool to search a virtual library of over 4M molecules for those predicted to be selective dual inhibitors of EGFR and IGF1R, acquiring 100% of the molecules that form the library's Pareto front after exploring only 8% of the library.</s><s xml:id="_5TgagF9">This workflow and associated open source software can reduce the screening burden of molecular design projects and is complementary to research aiming to improve the accuracy of binding predictions and other molecular properties.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="595.276" lry="779.528"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1" xml:id="_dGHRfJG">Introduction</head><p xml:id="_KY7gD9U"><s xml:id="_4t5CaqC">Molecular discovery aims to identify molecules that balance multiple, oen competing, properties.</s><s xml:id="_7naBj5S">The need to simultaneously optimize multiple properties is especially notable in drug discovery workows.</s><s xml:id="_JKsktgP">Small molecule drugs operating through direct single-target binding interactions must exhibit not only strong binding affinity for the target protein but also minimal off-target interactions and suitable pharmacokinetic properties. <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref></s><s xml:id="_Qu7cykW">2]<ref type="bibr" target="#b2">[3]</ref> One formulation of small molecule drug discovery is to identify compounds that bind strongly to a protein of interest and subsequently modify them to fulll remaining property constraints. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5</ref></s><s xml:id="_YmNZ2uP">A candidate molecule with high activity but a poor pharmacokinetic prole may ultimately be abandoned, resulting in wasted time and resources. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b5">6</ref></s><s xml:id="_EpvSVTy">electivity is one property that is oen considered only aer a hit with promising primary activity is identied. <ref type="bibr" target="#b0">1</ref></s><s xml:id="_7Uq7Zqh">Selectivity may be measured with binding assays against off-targets that are structurally similar to the primary target or known to be associated with adverse side effects (e.g., cytochromes P450 and the hERG channel). <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b6">7</ref></s><s xml:id="_vPyDuQh">Non-specic ligands that bind to many proteins in addition to the target may require additional optimization steps when compared to their selective counterparts. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b7">8</ref></s><s xml:id="_uJnymdf">onsideration of promiscuity early in a drug discovery project may aid in deprioritizing chemical series that are inherently nonselective. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b9">10</ref></s><s xml:id="_As2RbVQ">In other settings, binding interactions with multiple targets can be advantageous. <ref type="bibr" target="#b10">11</ref></s><s xml:id="_4hheAfq">Therapeutics for Alzheimer's disease <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref> and thyroid cancer <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref> have exhibited improved efficacy through affinity for multiple protein targets.</s><s xml:id="_ahKr6Xv">Optimizing affinity to multiple targets is another goal that can be brought into earlier stages of hit discovery. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17</ref></s><s xml:id="_sqXf7zn">nticipating protein-ligand interactions that contribute to potency and selectivity is possible, albeit imperfectly, with structure-based drug design techniques that employ scoring functions to estimate energetic favorability.</s><s xml:id="_QMC4mke">Docking to offtargets has been applied to improve the selectivity proles of identied compounds. <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref></s><s xml:id="_9th245H">9]<ref type="bibr" target="#b19">[20]</ref> These demonstrations have revealed that falsely predicted non-binders may incorrectly be categorized as selective because scoring functions designed for hit-nding typically aim to minimize the false positive rate (i.e., weak binders predicted to bind strongly), not the false negative rate (i.e., binders predicted not to bind). <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s xml:id="_Wp4dK6m">Although structurebased methods like docking are limited in their predictive accuracy, <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> docking-based virtual screens can still effectively enrich a virtual library for molecules that are more likely to exhibit target activity. <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref></s><s xml:id="_eQjUeNM">]<ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref> The computational cost of virtual screening <ref type="bibr" target="#b32">33</ref> has motivated the development of model-guided optimization methods that reduce the total number of docking calculations required to recover top-performing molecules. <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref></s><s xml:id="_js6wKKj">5]<ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref> As one example, Graff et al. <ref type="bibr" target="#b36">37</ref> only require the docking scores of 2.4% of a 100M member virtual library to identify over 90% of the library's top-50 000 ligands.</s><s xml:id="_RUyWScU">Similar principles apply when using more expensive evaluations such as relative binding free energy calculations, <ref type="bibr" target="#b40">41</ref> where a reduction of computational cost can be particularly benecial.</s><s xml:id="_RhwWcqE">These methods are designed to optimize a single property and are inherently single-objective optimizations.</s></p><p xml:id="_9uP8KkU"><s xml:id="_DjxjxuP">The need for model-guided optimization methods in virtual screening is heightened when multiple properties are screened.</s><s xml:id="_GpWaZXf">The resources required for a multi-objective virtual screen scale linearly with the number of screened properties ("objectives") and library size.</s><s xml:id="_fQBnkXY">In some settings, exhaustive screens of large virtual libraries (millions to billions) may be infeasible.</s><s xml:id="_GC88Tgc">Modelguided multi-objective optimization has the potential to reduce the computational cost of a multi-objective virtual screen without sacricing performance.</s><s xml:id="_epesxsx">Mehta et al. <ref type="bibr" target="#b41">42</ref> have previously applied Bayesian optimization to identify molecules that simultaneously optimize the docking score to Tau Tubulin Kinase 1, calculated octanol-water partition coefficient (clogP), <ref type="bibr" target="#b42">43</ref> and synthetic accessibility score (SA_Score). <ref type="bibr" target="#b43">44</ref></s><s xml:id="_pWu6zxy">Their implemented acquisition function is a product of acquisition scores for individual objectives, <ref type="bibr" target="#b41">42</ref> leading to the recovery of over 90% of the most desirable molecules aer scoring only 6% of the virtual library.</s><s xml:id="_xxC5Z2H">Multi-objective virtual screens involve multiple design choices primarily related to the acquisition strategy, which have not yet been compared in the context of virtual screening.</s><s xml:id="_nEPwftr">Further, existing methods for multi-objective virtual screening do not implement Pareto optimization.</s><s xml:id="_Txmv5zu">Pareto optimization aims to identify the molecules that form or are close to the Pareto front, for which an improvement in one objective necessitates a detriment to another.</s><s xml:id="_vYABtXU">Molecules that form the Pareto front optimally balance multiple desired properties, illustrate which combinations of objective values are possible, and reveal trade-offs in the objective space; this is not possible with scalarization.</s></p><p xml:id="_82kMQzp"><s xml:id="_5FTR4gg">In this work, we extend the molecular pool-based active learning tool MolPAL 37 to this setting of multi-objective virtual screening.</s><s xml:id="_XZ8FQdm">MolPAL is publicly available, open source, and can be adopted for multi-objective virtual screening with any desired set of objective functions, including those beyond structure-based drug design.</s><s xml:id="_nBSvEqn">We demonstrate through three retrospective case studies that MolPAL can efficiently search a virtual library for putative selective binders.</s><s xml:id="_PaM7And">We compare optimization performance across multi-objective acquisition functions and demonstrate the superiority of Pareto-based acquisition functions over scalarization ones.</s><s xml:id="_TkEmBqR">We also implement a diversity-enhanced acquisition strategy that increases the number of acquired scaffolds by 33% with only a minor impact on optimization performance.</s><s xml:id="_thuYbXr">Finally, we apply MolPAL to efficiently search the Enamine Screening Collection 45 of over 4 million molecules for selective dual inhibitors of EGFR and IGF1R as an exemplary 3-objective optimization.</s><s xml:id="_9xWQ3Pf">Aer exploration of only 8% of the virtual library, 100% of the library's nondominated points and over 60% of the library's top ∼0.1%, dened by non-dominated sorting, are identied by MolPAL.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2" xml:id="_VjEZ223">Multi-objective virtual screening with MolPAL</head><p xml:id="_vwqq3R8"><s xml:id="_wYr5aNn">MolPAL applies the multi-objective pool-based workow described in ref. 46, combining multi-objective Bayesian optimization and surrogate models to efficiently explore a virtual library for molecules that simultaneously optimize multiple properties (Fig. <ref type="figure" target="#fig_1">1</ref>).</s><s xml:id="_H9JbdcX">Similar workows have been demonstrated for the design of battery materials <ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref> and other functional materials. <ref type="bibr" target="#b49">[50]</ref><ref type="bibr" target="#b50">[51]</ref></s><s xml:id="_Aj4KzDW">1]<ref type="bibr" target="#b51">[52]</ref> As summarized in Algorithm S2, † objective values are rst calculated for a subset of the library, and surrogate models that predict each objective are trained on these initial observations.</s><s xml:id="_smaw2n8">Aer objective values are predicted for all candidate molecules, an acquisition function selects a set of promising molecules for objective function evaluation.</s><s xml:id="_fbZUF8Y">The surrogate models are then retrained with new observations, and the iterative loop repeats until a stopping criterion is met.</s></p><p xml:id="_5VH7ZjH"><s xml:id="_cQTfrJM">Relative to its initial release in ref. 37, MolPAL was extended primarily through modication of the acquisition strategy and handling of multiple surrogate models.</s><s xml:id="_jYRRz7Z">The multi-objective extension of MolPAL allows users to select between Pareto optimization and scalarization strategies.</s></p><p xml:id="_xEFNkrN"><s xml:id="_yJVmu24">Scalarization reduces a multi-objective optimization problem into a single-objective problem, oen through a weighted sum:</s></p><formula xml:id="formula_0">f scal ðxÞ ¼ X i l i f i ðxÞ;<label>(1)</label></formula><p xml:id="_uNtGqHh"><s xml:id="_5GuwAp8">with each l i denoting the relative importance of objective f i .</s><s xml:id="_wpaD7fA">Weighted sum scalarization requires the relative importance of objectives to be known before the optimization in order to assign weighting factors l.</s><s xml:id="_jVDus7y">Alternative scalarization strategies beyond a weighted sum include random scalarization <ref type="bibr" target="#b53">54,</ref><ref type="bibr" target="#b54">55</ref> and Chebyshev scalarization, <ref type="bibr" target="#b55">56,</ref><ref type="bibr" target="#b56">57</ref> but these are not yet implemented in MolPAL.</s><s xml:id="_BEsHYvz">Scalarization enables the use of single-objective acquisition functions, which include probability of improvement (PI) <ref type="bibr" target="#b57">58</ref> or expected improvement (EI) <ref type="bibr" target="#b58">59</ref> (Fig. <ref type="figure" target="#fig_2">2A</ref>), greedy, and upper condence bound (UCB) <ref type="bibr" target="#b59">60</ref> (Table <ref type="table">1</ref>).</s><s xml:id="_khBEXUC">Scalarization is implemented prior to surrogate model training, i.e., only one single-task surrogate model is necessary.</s><s xml:id="_2a7ydeE">Algorithm S1 † summarizes MolPAL's implementation of scalarized multi-objective optimization.</s></p><p xml:id="_y6HhGBy"><s xml:id="_e9yjZ8f">Pareto optimization is a multi-objective optimization strategy that reveals the trade-offs between objectives and does not require any measure of the relative importance of objectives.</s><s xml:id="_595Hb2w">Further, Pareto optimization aims to identify the entire Pareto front, a feature not guaranteed by single-objective methods such as weighted sum scalarization. <ref type="bibr" target="#b60">61,</ref><ref type="bibr" target="#b61">62</ref></s><s xml:id="_kJ5hNJk">Common multi-objective acquisition functions include the probability of hypervolume improvement (PHI), <ref type="bibr" target="#b52">53</ref> expected hypervolume improvement (EHI), <ref type="bibr" target="#b52">53</ref> non-dominated sorting (NDS), <ref type="bibr" target="#b62">63,</ref><ref type="bibr" target="#b63">64</ref> and Pareto upper condence bound (P-UCB). <ref type="bibr" target="#b64">65</ref></s><s xml:id="_qTsWnqx">These are natural extensions of single-objective acquisition functions (Table <ref type="table">1</ref>) that instead aim to increase the region, or hypervolume, dominated by the acquired points (Fig. <ref type="figure" target="#fig_2">2</ref>).</s><s xml:id="_cW2ZvVN">P-UCB and its single-objective analog UCB are not considered in this work.   </s><s xml:id="_bkkaGMh">extend the principles of PI and EI to multiple dimensions using the observed Pareto front (grey dashed line) rather than f*.</s><s xml:id="_UYFUQ7v">Probability of hypervolume improvement (PHI) represents the likelihood that acquisition of an unobserved point would increase the hypervolume by any amount.</s><s xml:id="_86rfqQQ">Expected hypervolume improvement (EHI) estimates the increase in hypervolume if the objective function value of such a point is scored. <ref type="bibr" target="#b52">53</ref></s><s xml:id="_9tunBvJ">Objectives are defined so that optimization corresponds to maximization.</s></p><p xml:id="_5VmDFAY"><s xml:id="_4BZ4uBT">Table <ref type="table">1</ref> Common single-objective acquisition functions and their multi-objective analogs.</s><s xml:id="_aEzybq6">ℙ and E represent probability and expected value, respectively.</s><s xml:id="_vAdJm3p">f* is the current best objective value, HV is hypervolume, and rank is the Pareto rank.</s><s xml:id="_z6s4HPb">Surrogate models provide prediction means m and standard deviations s for the objective value f of candidate point x.</s><s xml:id="_RMDFaFB">X acq is the set of points acquired in previous iterations.</s><s xml:id="_vvKjtHh">Bold variables are vectors.</s><s xml:id="_nD88e5X">N ðm; sÞ implies that the covariance matrix is treated as diagonal with entries s i 2 , i.e., uncertainty is uncorrelated across objective functions</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_z6BB9JP">Single-objective</head><p xml:id="_a52hS6j"><s xml:id="_VmuC3yJ">Multi-objective PI <ref type="bibr" target="#b57">58</ref> ℙ f ðxÞ$N ðmðxÞ;sðxÞÞ ½f ðxÞ .</s><s xml:id="_CDTKVZS">f * PHI <ref type="bibr" target="#b52">53</ref> ℙ fðxÞ$N ðmðxÞ;sðxÞÞ ½HVðX acq WxÞ .</s><s xml:id="_JgycdX6">HVðX acq Þ EI <ref type="bibr" target="#b58">59</ref> E f ðxÞ$N ðmðxÞ;sðxÞÞ ½maxff ðxÞ À f *; 0g EHI <ref type="bibr" target="#b52">53</ref> E fðxÞ$N ðmðxÞ;sðxÞÞ ½HVðX acq WxÞ À HVðX acq Þ Greedy m(x) NDS <ref type="bibr" target="#b62">63,</ref><ref type="bibr" target="#b63">64</ref> rank(m(x)) UCB <ref type="bibr" target="#b59">60</ref> m(x) + bs(x) P-UCB 65 rank(m(x) + bs(x))</s></p><p xml:id="_euNp3ZU"><s xml:id="_cCURMJW">Acquiring a batch of k points in a single iteration may be more efficient than sequential acquisition when objectives functions can be calculated in parallel.</s><s xml:id="_SyNSxak">"Top-k batching" naively selects the k points with the highest acquisition scores. <ref type="bibr" target="#b66">67</ref></s><s xml:id="_e2Bw3Hp">More sophisticated batch acquisition strategies iteratively construct optimal batches one point at a time by hallucinating objective function values. <ref type="bibr" target="#b67">[68]</ref><ref type="bibr" target="#b68">[69]</ref></s><s xml:id="_CBqCVhg">9]<ref type="bibr" target="#b69">[70]</ref><ref type="bibr" target="#b70">[71]</ref><ref type="bibr" target="#b71">[72]</ref><ref type="bibr" target="#b72">[73]</ref> Other strategies use heuristics to select batches that are diverse in the design space or objective space in order to improve the utility of a batch. <ref type="bibr" target="#b73">[74]</ref><ref type="bibr" target="#b74">[75]</ref></s><s xml:id="_2NNXqwA">5]<ref type="bibr" target="#b75">[76]</ref><ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref> MolPAL implements both naive top-k batching and diversity-enhanced acquisition strategies that apply clustering in both the design space and in the objective space (Section 5.5).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3" xml:id="_CqBw8Bp">Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1" xml:id="_drsfFdJ">Description of case studies</head><p xml:id="_RZ65PFN"><s xml:id="_CCXCNf7">We test MolPAL with three retrospective case studies with an emphasis on docking-predicted binding selectivity to compare optimization performance across acquisition functions.</s><s xml:id="_RAtbAXq">The pairs of objectives used in these case studies are exclusively docking scores even though the framework of MolPAL is more general.</s><s xml:id="_v4ySvpd">For example, this workow may be used to optimize docking scores to an ensemble of protein structures <ref type="bibr" target="#b79">80</ref> ("ensemble docking") or optimize multiple docking scoring functions provided with a single target. <ref type="bibr" target="#b80">[81]</ref><ref type="bibr" target="#b81">[82]</ref></s><s xml:id="_A2JHyyF">]<ref type="bibr" target="#b82">[83]</ref> Each case explores a virtual library of approximately 260k molecules and optimizes two competing docking score objectives from the DOCKSTRING benchmark. <ref type="bibr" target="#b83">84</ref></s><s xml:id="_uzNSNHC">Case 1's goal is modeled aer identifying antagonists of dopamine receptor D 3 (DRD3) that are selective over dopamine receptor D 2 (DRD2), which may enable effective treatment of various conditions without the side effects triggered by DRD2 antagonists. <ref type="bibr" target="#b84">[85]</ref><ref type="bibr" target="#b85">[86]</ref></s><s xml:id="_qw8bQJm">6]<ref type="bibr" target="#b86">[87]</ref> Case 2 treats Janus Kinase 2 (JAK2), a lukemia target, as the on-target and lymphocyte-specic protein tyrosine kinase (LCK) as the off-target. <ref type="bibr" target="#b87">88,</ref><ref type="bibr" target="#b88">89</ref></s><s xml:id="_guNwGP2">Finally, case 3 aims to identify selective inhibitors of insulin-like growth factor 1 receptor (IGF1R) <ref type="bibr" target="#b89">90,</ref><ref type="bibr" target="#b90">91</ref> that do not bind to cytochrome P450 3A4 (CYP3A4), <ref type="bibr" target="#b91">92,</ref><ref type="bibr" target="#b92">93</ref> an off-target known to impact the pharmacokinetic properties of drugs though metabolism. <ref type="bibr" target="#b93">[94]</ref><ref type="bibr" target="#b94">[95]</ref></s><s xml:id="_TQGxFR2">5]<ref type="bibr" target="#b95">[96]</ref> The property tradeoffs for each case are shown in Fig. <ref type="figure" target="#fig_3">3</ref>.</s><s xml:id="_7cAmrDy">Because both positive docking scores and scores of 0 should be interpreted as nonbinders, we clip docking scores to 0.</s></p><p xml:id="_zBkVeAN"><s xml:id="_wt3p2jb">We employ single-task directed message-passing neural networks <ref type="bibr" target="#b96">97,</ref><ref type="bibr" target="#b97">98</ref> for each objective as surrogate models (Section 5.4).</s><s xml:id="_zHM2JTt">An initial set of 2602 molecules is randomly sampled at the zeroth iteration, and 1% of the library (2602 molecules) is acquired in each subsequent iteration.</s><s xml:id="_GhXtged">Scalarization weighting factors (l 1 and l 2 in eqn (1)) were set to 0.5.</s><s xml:id="_Z8XQTax">Five trials with distinct initialization seeds were completed for each acquisition function.</s><s xml:id="_fey8jrg">Section 5 contains full implementation details.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2" xml:id="_VWaqEbx">Pareto acquisition functions outperform scalarization</head><p xml:id="_zYsaVmD"><s xml:id="_hxkBcYD">We characterize optimization performance with three metrics: fraction of the top ∼1% acquired, hypervolume (HV), and fraction of non-dominated points acquired.</s><s xml:id="_EtAdRDV">We motivate the selection of these metrics and describe their implementation in Section 5.6.</s></p><p xml:id="_2S9dhrU"><s xml:id="_vQr5Sfg">All Pareto optimization acquisition functions show substantial improvement over random acquisition according to the top ∼1% metric, with PHI performing most consistently across cases (Fig. <ref type="figure" target="#fig_4">4A-F</ref>).</s><s xml:id="_FHWgtAH">Analyzing the same metric, greedy is clearly the best scalarized acquisition function despite its poor performance in case 3 relative to PHI and EHI.</s><s xml:id="_ntvfZbZ">Only in case 1 does the best scalarization acquisition function outperform the best Pareto acquisition function.</s><s xml:id="_RzgBcp4">Performance metrics using the acquisition function described by Mehta et al. <ref type="bibr" target="#b41">42</ref> (MO-MEMES) are included as an additional baseline in Tables <ref type="table">S1-S3</ref>.</s><s xml:id="_aZ9tSJr">† Pareto optimization acquisition functions consistently outperform MO-MEMES.</s></p><p xml:id="_yJ5wbud"><s xml:id="_Ugj2EVg">When performance is measured by the fraction of nondominated points acquired, EHI and PHI outperform scalarization acquisition functions (Fig. <ref type="figure" target="#fig_5">5</ref>) even though the degree of improvement varies across cases.</s><s xml:id="_jaW4yMN">The sensitivity of the hypervolume metric to outliers on the Pareto front leads to noisy hypervolume proles (Fig. <ref type="figure" target="#fig_2">S2 †</ref>).</s><s xml:id="_TBFzk4B">Similar trends are observed when measuring the inverted generational distance metric (Fig. <ref type="figure" target="#fig_3">S3 †</ref>).</s><s xml:id="_wd4MmJ2">Overall, Pareto optimization acquisition functions strongly outperform or match the performance of scalarization for the pairs of objectives and virtual library considered.</s></p><p xml:id="_HWvqPaA"><s xml:id="_C4pUN3N">The variation in relative performance of different acquisition functions across evaluation metrics is noteworthy.</s><s xml:id="_ZBYxWxh">For example, greedy scalarization performs quite well in the top ∼1% metric for all cases but worse than random acquisition according to hypervolume and fraction of non-dominated points in case 3. The results shown here highlight the importance of assessing the performance across different sets of objectives.</s><s xml:id="_WyMS8Jq">Despite the variation across cases and metrics, EHI and PHI consistently perform as well as scalarization or substantially better than scalarization.</s><s xml:id="_szCdryx">These acquisition functions are suitable choices for new sets of objectives.</s><s xml:id="_pmsmfGR">Alternatively, when a previously unexplored set of objectives is to be optimized, a retrospective study on a scored subset of the library can inform the selection of a suitable acquisition strategy.</s><s xml:id="_NtAKsVV">Each reported metric corresponds to distinct optimization goals (Section 5.6); the primary application of a multi-objective virtual screen should inform which metric to use for acquisition function comparison and selection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3" xml:id="_m9YA6eb">Clustering-based acquisition improves molecular diversity</head><p xml:id="_TcWSQs2"><s xml:id="_8uThMzU">Scoring functions used in structure-based virtual screening can exhibit systematic errors that bias selection toward specic interactions. <ref type="bibr" target="#b98">99</ref></s><s xml:id="_wKXbW4u">This poses a risk for experimental validation if specic scaffolds are overrepresented in the top-scoring molecules.</s><s xml:id="_b3DwVEk">Selecting a structurally diverse set of candidates is one strategy to mitigate this risk and can be achieved via a diversity-enhanced acquisition strategy (Section 5.5).</s><s xml:id="_fHhWr4A">First, a set of molecules larger than the target batch size is selected according to the acquisition function and is then partitioned into a number of clusters equal to the batch size in feature (e.g., molecular ngerprint) space.</s><s xml:id="_pJHTWFf">The molecule with the best acquisition score in each cluster is acquired.</s><s xml:id="_eS3hC75">We analyzed the performance of diversity-enhanced acquisition for case 3, using PHI as the acquisition function.</s><s xml:id="_6UWGdA6">All hyperparameters were the same as those used for previous experiments (Section 5).</s></p><p xml:id="_CZRrBqd"><s xml:id="_bxj3sJc">Feature space clustering slightly hinders optimization performance according to all four performance metrics (Fig. <ref type="figure" target="#fig_6">6A-E</ref>), but it also increases the number of graph-based Bemis-Murcko scaffolds 100 acquired by 33% when compared to a naïve batch construction strategy.</s><s xml:id="_BkPRNvM">This degradation in measured performance is expected given that the performance metrics do not consider the overall diversity of the selected molecules.</s><s xml:id="_PY7CVde">The increased structural diversity of the selected molecules can be qualitatively visualized via dimensionality reduction through UMAP 101 (Fig. <ref type="figure" target="#fig_4">S4 †</ref>).</s><s xml:id="_FJ6BjUw">Certain multi-objective optimization methods such as NSGA-II 64 also incorporate objective space diversity, i.e., the selection of points better distributed along the Pareto front. <ref type="bibr" target="#b45">46</ref></s><s xml:id="_Y8NS559">We nd that clustering in the objective space during acquisition (Section 5.5) mildly hinders performance in all optimization metrics (Fig. <ref type="figure" target="#fig_6">6A-E</ref>).</s><s xml:id="_PXyQ7mh">An acquisition strategy that considers diversity in both the objective space and feature space (Section 5.5) performs similarly to the standard acquisition strategy across most optimization metrics (Fig. <ref type="figure" target="#fig_6">6A-D</ref>) while acquiring a more structurally diverse set of molecules when compared to standard acquisition (Fig. <ref type="figure" target="#fig_6">6F</ref> and <ref type="figure" target="#fig_4">S4 †</ref>).</s><s xml:id="_B9dxr7r">Overall, we recommend the use of feature space clustering if having structurally distinct candidates is a priority for experimental validation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4" xml:id="_BxkyKRF">MolPAL scales to 3 objectives and larger libraries</head><p xml:id="_sGTw2sB"><s xml:id="_zjAxfaV">As a nal demonstration, we show that MolPAL scales well to larger virtual libraries and more than two objectives by searching the Enamine Screening Collection 45 of over 4 million molecules for those that optimize three docking objectives.</s><s xml:id="_kpth9bW">The objectives were dened to identify putative dual inhibitors of IGF1R and EGFR 102-104 with selectivity over CYP3A4 <ref type="bibr" target="#b93">[94]</ref><ref type="bibr" target="#b94">[95]</ref><ref type="bibr" target="#b95">[96]</ref><ref type="bibr">105</ref> which could in principle serve as starting points for esophageal cancer  © 2024 The Author(s). Publ</s><s xml:id="_jNuQDFx">shed by the Royal Society of Chemistry Digital Discovery, 2024, 3, 467-481 | 473 Paper Digital Discovery Open Access Article.</s><s xml:id="_FB9hVJx">Published on 15 January 2024.</s><s xml:id="_R66Px7u">Downloaded on 8/5/2025 1:00:38 AM.</s><s xml:id="_wfkvZKW">This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</s></p><p xml:id="_SZqKPPE"><s xml:id="_dksgNKQ">therapeutics.</s><s xml:id="_VhpnE6p">To analyze performance according to the four considered evaluation metrics, we perform this search retrospectively aer docking the entire library using DOCKSTRING's protocol for each target 84 (Section 5.1).</s><s xml:id="_jubtSBn">The distributions of individual objectives for the entire library are shown in Fig. <ref type="figure" target="#fig_7">7</ref>.</s></p><p xml:id="_NfM5ZtG"><s xml:id="_CRZdTN6">We use PHI acquisition without clustering and acquire 1% of the library at each iteration, repeating each experiment three times.</s></p><p xml:id="_xBb8V4u"><s xml:id="_qZ2VnnV">MolPAL succeeds in acquiring 100% of the library's nondominated points in all three replicates aer exploring only 8% of the search space (Fig. <ref type="figure" target="#fig_8">8C</ref>), a 9X improvement of in the fraction of acquired non-dominated points over random acquisition.</s><s xml:id="_M4bZHwu">At this same degree of exploration (8% of the library), over 60% of the library's top ∼0.1% molecules have been identied (Fig. <ref type="figure" target="#fig_8">8A</ref>).</s><s xml:id="_dsHK3w4">Improvements in IGD and hypervolume with MolPAL over random acquisition are also notable (Fig. <ref type="figure" target="#fig_8">8</ref> and Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_BbW7Wjh">The results of this retrospective run indicate that MolPAL can substantially reduce the computational resources required to identify molecules that simultaneously optimize multiple properties from a virtual library of millions of molecules.</s></p><p xml:id="_DQvvSmX"><s xml:id="_aFevWcS">The virtual library's true Pareto front of 39 molecules, all of which were recovered by MolPAL, is visualized in Fig. <ref type="figure" target="#fig_9">9</ref>.</s><s xml:id="_a6HF4Sa">The structures of all non-dominated molecules are shown in Fig. <ref type="figure" target="#fig_8">S6-S8</ref>.</s><s xml:id="_79yU4X5">† The structures of these molecules, several of which look more like dye molecules than drug-like molecules, expose some remaining challenges of docking for selectivity prediction.</s><s xml:id="_fCtUJXq">Molecules predicted to be non-binders to CYP3A4, such as M4 and M20 in Fig. <ref type="figure" target="#fig_9">9</ref>, are relatively large molecules that do not t inside the pocket of CYP3A4, leading to steric clashes and less favorable binding energetics.</s><s xml:id="_WgPKpcZ">The ability for such molecules to score well against the IGF1R and EGFR but poorly against CYP3A4 is exemplied by the computed docking poses and protein-ligand interactions of M4 (Fig. <ref type="figure" target="#fig_5">S5 †</ref>).</s><s xml:id="_pVc83zR">Although steric clashes may be a valid reason for hypothetical selectivity towards EGFR/IGF1R over CYP3A4, the molecules predicted to be most selective (e.g., M4 and M20) are not attractive candidates for experimental validation.</s><s xml:id="_fVN4tem">In practice, dominated molecules that are close to the identied Pareto front should  also be considered for experimental validation or follow-up studies.</s><s xml:id="_JR2Zqge">Molecules that are obviously not suitable starting points for a drug discovery campaign, including those in Fig. <ref type="figure" target="#fig_9">9</ref>, should be deprioritized for experimental testing.</s><s xml:id="_WfymezM">A ligand efficiency score may also be used as an objective function to penalize very large molecules. 106</s><s xml:id="_Zz8e3Zu">Nevertheless, given the imperfections of docking as an oracle function, MolPAL perfectly identies the Pareto front at a reduced computational cost and scores well in terms of all evaluation metrics.</s><s xml:id="_EFrF2Xy">We do not intend to nominate the visualized molecules as starting points for a drug discovery project but instead aim to demonstrate the ability for MolPAL to efficiently molecules that optimize any set of oracles such as those that predict binding affinity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4" xml:id="_bcMpGA7">Conclusion</head><p xml:id="_JWJnTGw"><s xml:id="_3UZKp7v">We have introduced an open source multi-objective extension of the pool-based optimization tool MolPAL 37 and demonstrated its ability to accelerate docking-based multi-objective virtual screening.</s><s xml:id="_n6PFbKh">MolPAL provides a exible Pareto optimization framework that allows users to systematically vary key design choices like acquisition strategy.</s><s xml:id="_bxgFQks">MolPAL is most appropriate for optimizing objectives that are more expensive to calculate than surrogate molecular property prediction models.</s><s xml:id="_AKzBHtv">Beyond docking, these include objectives that require binding free energy calculations, quantum mechanical simulations, or experiments to measure.</s><s xml:id="_WBdCzvX">Objectives that are calculable in CPU milliseconds, such as SA_Score or clogP, can be screened exhaustively and do not warrant model-guided optimization tools.</s><s xml:id="_HPyZYq9">MolPAL could also be applied to consensus docking by optimizing multiple scoring functions that predict binding affinity to the same target. <ref type="bibr" target="#b80">[81]</ref><ref type="bibr" target="#b81">[82]</ref></s><s xml:id="_zMjm95j">2]<ref type="bibr" target="#b82">[83]</ref> MolPAL is designed to exibly accommodate custom objectives and facilitate the optimization of other property predictions relevant to molecular design.</s><s xml:id="_zSkvPA4">We rst assessed MolPAL on three two-objective case studies that aim to identify putative selective binders.</s><s xml:id="_MqxhGpg">We found that expected hypervolume improvement and probability of hypervolume improvement, both Pareto optimization acquisition functions, consistently performed as well as or better than scalarization.</s><s xml:id="_guFUk6R">A diversity-enhanced acquisition strategy that applies clustering in molecular ngerprint space was found to increase the number of Bemis-Murcko scaffolds observed by 33% when compared to standard acquisition.</s><s xml:id="_75FmBdk">Finally, we demonstrated that MolPAL can efficiently search large virtual libraries and optimize three objectives simultaneously through a case study aiming to identify putative selective dual inhibitors from the Enamine Screening Collection of over 4 million molecules; MolPAL acquired all of the library's non-dominated molecules aer exploring only 8% of the library in all three replicates.</s></p><p xml:id="_uYybzyP"><s xml:id="_8jd6MUJ">Exploration of other multi-objective optimization approaches, such as random scalarization and Chebyshev scalarization, in the context of molecular optimization could expose benets of strategies not explored in this work.</s><s xml:id="_4b3azuk">Other published diversity-enhanced acquisition strategies <ref type="bibr" target="#b78">79,</ref><ref type="bibr" target="#b106">107</ref> may have the potential to improve both molecular diversity and optimization performance.</s></p><p xml:id="_R7sjzxp"><s xml:id="_XXputf9">While the use of docking to off-targets as a proxy for selectivity is well precedented, <ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref> the high false negative rates of docking screens (i.e., binders predicted to be nonbinding) pose a risk for experimental validation of molecules predicted to be selective. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr">108</ref></s><s xml:id="_4B2jSk5">Pharmacophore models and scoring functions that are designed for off-target activity 9,19,109 could be more appropriate for cross-docking for selectivity in the future.</s><s xml:id="_5K64JhE">Because MolPAL is a general multi-objective optimization strategy that can be applied to any combination of oracle functions, it will maintain its relevance as these oracle functions improve in time.</s><s xml:id="_fC4W2AD">Future efforts applying MolPAL to hit discovery and early-stage molecular design are necessary to validate the benets of considering multiple objectives at early stages of molecular discovery.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5" xml:id="_2Ck6H2n">Methods</head><p xml:id="_gKZRPAJ"><s xml:id="_FbzxNs2">All code required to reproduce the reported results can be found in the branch of MolPAL at <ref type="url" target="https://github.com/coleygroup/molpal/tree/multiobj">https://github.com/coleygroup/  molpal/tree/multiobj</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1" xml:id="_5fR6UhX">Data collection</head><p xml:id="_n7h9Bwc"><s xml:id="_BbRYM3j">All docking scores used in Sections 3.2 and 3.3 were used without reprocessing from the DOCKSTRING benchmark <ref type="bibr" target="#b83">84</ref> (downloaded June 2023).</s><s xml:id="_5nhVeDM">For the larger scale study in Section 3.4, the Enamine Screening Collection of over 4 million compounds <ref type="bibr" target="#b44">45</ref> (downloaded May 2023) was docked against IGF1R, EGFR, and CYP3A4 using DOCKSTRING <ref type="bibr" target="#b83">84</ref> with default settings for each target.</s><s xml:id="_722xhjA">Before docking, molecules were stripped of salts using RDKit's SaltRemover module. <ref type="bibr">110</ref></s><s xml:id="_XMWf44v">Of the 4 032 152 in the library, 4 010 199 were docked successfully to CYP3A4, 4 010 191 to IGF1R, and 4 010 187 to EGFR.</s><s xml:id="_UCQKvp4">Unsuccessful docking calculations resulted primarily from failures during the ligand preparation process.</s><s xml:id="_qqMvXZT">The full set of docking scores are available at https://gshare.com/articles/dataset/</s><s xml:id="_WNwaHWh">Enamine_screen_CYP3A4_EGFR_IGF1R_zip/23978547.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2" xml:id="_qWhnfgN">Objectives</head><p xml:id="_Vncbrf3"><s xml:id="_2CdUhpD">Docking scores to on-targets were minimized objectives, and scores to off-targets were maximized objectives.</s><s xml:id="_yvvsSXf">A positive docking score is not meaningfully different from a docking score of zero.</s><s xml:id="_JRB68qZ">We therefore adjust docking objectives to be:</s></p><formula xml:id="formula_1">f dock (x) = min(0,f(x))<label>(2)</label></formula><p xml:id="_gpYSnks"><s xml:id="_QwVA2vU">where f(x) is the raw docking score and f dock (x) is the minimized (for on-targets) or maximized (for off-targets) objective.</s><s xml:id="_r3ScQdf">Clipping docking scores in this manner also mitigates the effect of outliers on Pareto optimization metrics like hypervolume.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3" xml:id="_MUnJ9HJ">Acquisition functions</head><p xml:id="_sAFWyFq"><s xml:id="_Wg8sDv6">We modify PHYSBO's implementation 111 of expected hypervolume improvement and probability of hypervolume improvement, which applies the algorithm proposed</s></p><note type="other" xml:id="_vphY5b8">by Couckuyt et al. 112</note><p xml:id="_XEDhwXG"><s xml:id="_QBs4pje">MolPAL uses the utility in pygmo 113 for nondominated sorting in two dimensions.</s><s xml:id="_PQ9HF8G">In more than three dimensions, MolPAL iteratively identies non-dominated points using the Pareto class in PHYSBO 111 and removes those points from the unranked set until enough points have been ranked.</s></p><p xml:id="_VCjDyRf"><s xml:id="_eyRMaRz">In the scalarization runs, f was calculated according to eqn (1) with l 1 = l 2 = 0.5.</s><s xml:id="_UNRpSSf">For prediction mean m, prediction standard deviation s, and current maximum value f*, expected improvement and probability of improvement in the scalarization runs were calculated as:</s></p><formula xml:id="formula_2">EIðx; f *Þ ¼ ðmðxÞ À f * þ xÞ$F mðxÞ À f * þ x sðxÞ þsðxÞ$f mðxÞ À f * þ x<label>sðxÞ</label></formula><formula xml:id="formula_3">PIðx; f *Þ ¼ F mðxÞ À f * þ x<label>sðxÞ</label></formula><formula xml:id="formula_4">GreedyðxÞ ¼ mðxÞ (<label>3</label></formula><formula xml:id="formula_5">)</formula><p xml:id="_U7BZrDT"><s xml:id="_KhzDrRv">where F is the cumulative distribution function of the standard normal distribution and f is the probability density function of the standard normal distribution function.</s></p><p xml:id="_guzp4s7"><s xml:id="_Jt4RJ75">x is a hyperparameter that controls the competitiveness of the sampling, <ref type="bibr" target="#b57">58</ref> which we set to 0.01.</s><s xml:id="_psh48pk">Higher values of x encourages exploration of uncertain points, while low values prioritize prediction means. <ref type="bibr" target="#b57">58</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.4" xml:id="_xEk3xcV">Surrogate model</head><p xml:id="_qkYuBEH"><s xml:id="_Mp9aA98">Because the optimization campaigns explored in this study comprise batches of thousands of molecules, we elect to use a directed message-passing neural network architecture <ref type="bibr" target="#b96">97</ref> as the surrogate model for all runs.</s><s xml:id="_3FDhh5s">MolPAL contains a PyTorch 114 implementation of ChemProp <ref type="bibr" target="#b96">97,</ref><ref type="bibr" target="#b97">98</ref> as in the original publication. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_DQWXPAM">We use an encoder depth of 3, directed edge messages only (no atom messages), a hidden size of 300, ReLU activation, and two layers in the feed-forward neural network as default parameters.</s><s xml:id="_jEQ6T4q">The model was trained with an initial learning rate of 10 -4 using a Noam learning rate scheduler and an Adam optimizer.</s><s xml:id="_v8AmQNR">In each iteration, the model is retrained from scratch, as this was found to provide a benet over ne-tuning. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_JtGABTb">e use mean-variance estimation 115,116 for surrogate model uncertainty quantication.</s><s xml:id="_6cBAD4v">The surrogate model is trained to predict both the mean f(x) and the variance of the estimation s 2 (x) via a negative log likelihood loss function:</s></p><formula xml:id="formula_6">Lðf ðxÞ; mðxÞ; sðxÞÞ ¼ ln2p 2 þ 1 2 lns 2 ðxÞ þ ðmðxÞ À yðxÞÞ 2 2s 2 ðxÞ<label>(4)</label></formula><p xml:id="_bg7bk8H"><s xml:id="_un4MstF">where f(x) is the true objective value, m is the predicted mean, and s 2 (x) is the predicted variance.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5" xml:id="_sfvZvNZ">Clustering</head><p xml:id="_Y9649MH"><s xml:id="_JnEpGgA">We implement three diversity-enhancing acquisition strategies using clustering: in the feature space, in the objective space, and in both (Section 3.3).</s><s xml:id="_bEdDF8e">Feature space clustering is performed according to 2048-bit atom-pair ngerprints 117 calculated using the function in RDKit 110 with the minimum length and maximum length of paths between pairs to 1 and 3, respectively.</s><s xml:id="_nMvpmCh">Atom pair ngerprints have been shown to outperform other extended connectivity ngerprints in recovering 3D-shape analogs 118 and ranking close analogs by structural similarity. <ref type="bibr">119</ref></s><s xml:id="_jp4CQ3F">The predicted objective means were used for clustering in the objective space.</s></p><p xml:id="_SKH5fMB"><s xml:id="_FDTF5y3">The acquisition strategy rst selects a superset of molecules according to the acquisition scores as in a standard acquisition strategy.</s><s xml:id="_5B27RS3">In our trials, the size of the superset is 10X the batch size, b.</s><s xml:id="_5fXeYtB">Then, the superset is clustered according to molecular ngerprints or predicted objective values.</s><s xml:id="_3wQWz8b">We use the implementation of 120 in scikit-learn 121 with b clusters, 10 random initializations, an initialization size of 3b, and a reassignment ratio of 0 for batch size b.</s><s xml:id="_ypEX6fX">Although b clusters are specied, some clusters may be returned as empty in the case of a low-dimensional cluster basis.</s><s xml:id="_7zc3jHa">We ensure that b points are acquired by iteratively looping through all clusters, beginning with the largest clusters, and acquiring the molecule in the cluster with the highest acquisition score.</s><s xml:id="_bSZtK9Y">This process is continued until b molecules are acquired.</s></p><p xml:id="_MwkxDtE"><s xml:id="_KEq3cah">When clustering in both the feature and objective spaces, the superset is rst clustered in the objective space into (b/2) clusters, and (b/2) points are acquired by iterating through the clusters and selecting the molecule with the highest acquisition score.</s><s xml:id="_DNgGagt">The superset is then supplemented with the b/2 unacquired candidate points that have the highest acquisition scores.</s><s xml:id="_pMbWBqg">Then, the superset is clustered in the atom-pair ngerprint space into b -(b/2) clusters, and the point with the highest acquisition score in each cluster is acquired.</s><s xml:id="_7YPJAu2">Thus, when both forms of clustering are used, effectively b/2 points are selected to improve objective space diversity, and b/2 points are selected to improve feature space diversity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6" xml:id="_WKw8s7U">Performance metrics</head><p xml:id="_zkf9j9t"><s xml:id="_V9QAf8h">Four performance metrics designed for Pareto optimization were measured to holistically assess the performance of Mol-PAL.</s><s xml:id="_9mb7eX5">The underlying goal of a multi-property virtual screen (e.g., understanding the trade-offs between objectives, identifying a set of potentially promising selective inhibitors) can guide which evaluation metric to be deemed most important.</s><s xml:id="_GhUSKmM">Reported metrics and the motivation for selecting each is described below.</s></p><p xml:id="_nPuHbZy"><s xml:id="_3RPZbWB">5.6.1 Fraction of top ∼k%.</s><s xml:id="_W9nFspe">Virtual screening workows based on active learning are oen evaluated using a top-k metric: the fraction of the true top-k molecules that have been acquired.</s><s xml:id="_zHv7zDe">Using a top-k metric captures the goal of separating promising molecules from the bulk while acknowledging that docking scores are imperfect and imprecise predictors of binding affinity.</s><s xml:id="_rFmXtnr">The best observed performance of a single compound is a less useful metric in this context, as there is a high likelihood it would not validate as a binder experimentally.</s></p><p xml:id="_8JpKBsa"><s xml:id="_cvS7tRr">For multi-property virtual screening, the set of top-k molecules is not well-dened.</s><s xml:id="_ApfGVMj">We opt to dene the top ∼k% through non-dominated sorting of the library (Fig. <ref type="figure" target="#fig_1">S1 †</ref>).</s><s xml:id="_ehcg9qk">The nondominated points in the library are iteratively selected and removed from the candidate pool until $k% of the library has been selected.</s><s xml:id="_6avrsVk">These points then serve as the top ∼k%.</s><s xml:id="_m6HrcYF">Because multiple points are selected as part of the top ∼k% in each iteration (i.e., all points of a certain Pareto rank), the fraction is slightly larger than k%.</s></p><p xml:id="_RYrv8AZ"><s xml:id="_jTRp8eJ">The top ∼k% metric best describes virtual screens aiming to identify many molecules roughly close to the Pareto front.</s><s xml:id="_tJtCb69">Compared to other metrics that consider points on or much closer to the Pareto front, it best captures the expectation that not all top-performing molecules will validate experimentally.</s></p><p xml:id="_jKsmCvy"><s xml:id="_WJeQbZg">5.6.2</s><s xml:id="_hM3Znyz">Fraction of non-dominated points.</s><s xml:id="_hf7VUCM">In some multiproperty screens, the aim may be to elucidate as many points on the true Pareto front as possible.</s><s xml:id="_xryxPpm">This enables the shape of the Pareto front and the inherent trade-off between objectives to be well-understood.</s><s xml:id="_Hg6CCVQ">A metric related to only the true nondominated points is most appropriate in these cases.</s><s xml:id="_U7BGYP8">The library's non-dominated points are identied using nondominated sorting (Section 5.3), and this metric is simply the fraction of the non-dominated molecules that were acquired.</s></p><p xml:id="_H7yDVmP"><s xml:id="_w6MQx3k">5.6.3</s><s xml:id="_Ffa8eJu">Hypervolume.</s><s xml:id="_FccQUZx">Hypervolume is a common metric used to assess the performance of multi-objective optimization methods. 122</s><s xml:id="_362DdFG">It measures the size of the region dominated by the Pareto front; in a bi-objective optimization, the hypervolume is the area dominated by the acquired points (Fig. <ref type="figure" target="#fig_1">S1B †</ref>).</s><s xml:id="_SKsj5Aw">Importantly, the hypervolume can be very sensitive to outliers, leading to high variability across repeat experiments.</s><s xml:id="_DsXv57w">Because outliers may fail to be experimentally validated, the strong sensitivity of hypervolume to specic points makes it slightly misleading.</s><s xml:id="_78tKU8Q">We use the python package pygmo 113 to calculate hypervolume and report it as the fraction of the virtual library's total hypervolume.</s><s xml:id="_WGngs8A">In contrast to the other evaluated metrics, the absolute hypervolume can be measured in prospective studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.7" xml:id="_2juYmUx">Scaffold analysis</head><p xml:id="_AspR6cn"><s xml:id="_4D4mCAx">To quantify the improvement in molecular diversity using diversity-enhanced acquisition, we count the number of observed Bemis-Murcko scaffolds 100 using RDKit's and functions.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_jTgvK2x"><s xml:id="_suDJMZC">For model-guided Pareto optimization, either a multi-task surrogate model, multiple single-task surrogate models, or a combination thereof is needed to predict the set of objective function values.</s><s xml:id="_VuD37DM">As outlined in Algorithm S2, † MolPAL trains N single-task surrogate models to predict N objectives to circumvent the challenge of loss function weighting in multitask learning.<ref type="bibr" target="#b65">66</ref></s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1</head><label>1</label><figDesc><div><p xml:id="_spPXDbR"><s xml:id="_TaZHuT9">Fig. 1 Overview of MolPAL's workflow for multi-objective optimization.</s><s xml:id="_FMmXXGC">A surrogate model is first trained with an initial training set of randomly sampled molecules.</s><s xml:id="_RQpEbg3">Predictions and uncertainties from each surrogate model inform which molecules in the library to score next.</s><s xml:id="_VVedJzS">After these acquired molecules are scored, each surrogate model is retrained, and the iterative loop continues.</s><s xml:id="_ysB6AE8">Once a stopping criterion is met, the set of observed points and their objective values can be analyzed.</s></p></div></figDesc><graphic coords="3,90.77,50.57,413.72,196.84" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2</head><label>2</label><figDesc><div><p xml:id="_Jjx8Jyc"><s xml:id="_2ybnSjQ">Fig. 2 Depiction of acquisition functions in Bayesian optimization.</s><s xml:id="_QCKc9Cv">(A) Probability of improvement (PI) estimates the likelihood that an as-yet unobserved objective function value exceeds the current maximum value f*.</s><s xml:id="_aGM9FPp">Expected improvement (EI) estimates the amount that f* would increase if an unobserved point is acquired. 53</s><s xml:id="_sZUXDdq">(B) Non-dominated sorting assigns integer "Pareto ranks" to each candidate.</s><s xml:id="_9YQfhwp">(C) Hypervolumebased acquisition functions<ref type="bibr" target="#b52">53</ref> extend the principles of PI and EI to multiple dimensions using the observed Pareto front (grey dashed line) rather than f*.</s><s xml:id="_4AZXFhC">Probability of hypervolume improvement (PHI) represents the likelihood that acquisition of an unobserved point would increase the hypervolume by any amount.</s><s xml:id="_vPxEgBE">Expected hypervolume improvement (EHI) estimates the increase in hypervolume if the objective function value of such a point is scored.<ref type="bibr" target="#b52">53</ref></s><s xml:id="_JaKBGPD">Objectives are defined so that optimization corresponds to maximization.</s></p></div></figDesc><graphic coords="3,84.70,317.82,425.95,128.92" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3</head><label>3</label><figDesc><div><p xml:id="_EntMc3n"><s xml:id="_Bm9kFvh">Fig. 3 Docking scores in the DOCKSTRING dataset 84 for (A) case 1, (B) case 2, and (C) case 3.</s><s xml:id="_dzrbzVr">All molecules considered in the top ∼1%, as determined by NDS rank (Section 5.6), are shown as magenta points, with the remaining data in grey.</s><s xml:id="_gtbXGPP">There are 2986 (1.15%), 2651 (1.02%), and 3261 (1.25%) molecules in the top ∼1% for cases 1, 2, and 3, respectively.</s></p></div></figDesc><graphic coords="4,84.70,565.29,425.95,125.46" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4</head><label>4</label><figDesc><div><p xml:id="_TMVR39d"><s xml:id="_b37uUUN">Fig. 4 Fraction of the top ∼1% acquired and inverted generational distance (IGD) for case 1, 2, and 3. (A, C and E) Fraction of top ∼1% using Pareto optimization acquisition functions (left) and scalarized acquisition functions (right).</s><s xml:id="_MmWdQfd">(B, D and F) Fraction of the top ∼1% acquired after 6 iterations.</s><s xml:id="_ytsZTy3">(G-I) IGD after 6 iterations for case 1 (G), case 2 (H), and case 3 (I).</s><s xml:id="_Kmkba3F">Error bars (B, D, F, G-I) and shaded regions (A, C and E) denote ± one standard deviation across five runs.</s></p></div></figDesc><graphic coords="5,84.70,50.57,425.95,357.39" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 5</head><label>5</label><figDesc><div><p xml:id="_dmt9WgH"><s xml:id="_CkZuyXz">Fig. 5 Identification of molecules on the true Pareto front.</s><s xml:id="_D92VbaM">(A) Fraction of non-dominated points acquired for cases 1, 2, and 3. (B) Final Pareto front acquired in case 3 using probability of greedy, expected hypervolume improvement (EHI), expected improvement (EI), and hypervolume improvement (PHI) acquisition, with the true Pareto front shown in grey.</s><s xml:id="_q4wVkTG">The Pareto front identified with greedy acquisition poorly reflects the shape of the true Pareto front, a discrepancy captured well by the fraction of non-dominated points metric.</s><s xml:id="_Byk6bHn">Each plot represents individual runs, all initialized with the same model seed and starting acquired set.</s><s xml:id="_Q47sGUb">Error bars denote ± one standard deviation across five runs.</s></p></div></figDesc><graphic coords="6,84.70,50.57,425.95,264.87" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 6</head><label>6</label><figDesc><div><p xml:id="_gKCjBKN"><s xml:id="_EDGsRx2">Fig. 6 Impact of clustering in fingerprint and objective space on optimization performance.</s><s xml:id="_cDenHsm">(A) Fraction of top ∼1% acquired.</s><s xml:id="_TTAenHV">(B) Fraction of top ∼1% acquired acquired after 6 iterations.</s><s xml:id="_3Nt99pC">(C) Inverted generational distance (IGD) after 6 iterations.</s><s xml:id="_FgpeFaH">(D) Hypervolume profiles.</s><s xml:id="_PDW4NGn">(E) Fraction of the library's non-dominated points acquired after 6 iterations.</s><s xml:id="_RVHrEaj">(F) Number of distinct graph-based Bemis-Murcko scaffolds acquired.</s><s xml:id="_VQv7K8F">Error bars (B, C and E) and shaded regions (A, D and F) denote ± one standard deviation across five runs.</s></p></div></figDesc><graphic coords="6,84.70,393.90,425.95,286.87" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig. 7</head><label>7</label><figDesc><div><p xml:id="_ryNvTdb"><s xml:id="_6TwXPVS">Fig. 7 Distributions of objective function values to be maximized for a retrospective 3-objective virtual screen.</s><s xml:id="_kWRyGtW">(A and B) Docking scores for targets IGF1R and EGFR, respectively.</s><s xml:id="_GykqMEr">(C) Docking scores for off-target CYP3A4.</s></p></div></figDesc><graphic coords="7,84.70,50.57,425.95,97.57" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 8</head><label>8</label><figDesc><div><p xml:id="_yBpMpz8"><s xml:id="_9ckez74">Fig. 8 Performance of MolPAL for the identification of selective dual IGF1R/EGFR inhibitors from the 4M-member Enamine screening library as an exemplary three-objective optimization.</s><s xml:id="_Y8X5Jgg">Profiles are depicted for the fraction of (A) top ∼0.1%, (B) top ∼0.5%, and (C) non-dominated points acquired, as well as the (D) hypervolume.</s></p></div></figDesc><graphic coords="7,84.70,373.44,425.95,317.25" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig. 9</head><label>9</label><figDesc><div><p xml:id="_bnnwj6u"><s xml:id="_FKM9RPB">Fig.9Visualization of the Pareto front for the 3-objective optimization for the identification of putative selective dual inhibitors.</s><s xml:id="_Qcx567M">All nondominated points depicted were acquired by MolPAL after scoring only 8% of the virtual library.</s><s xml:id="_egtDJn5">Structures for some molecules on the Pareto front are shown.</s><s xml:id="_seEJhVT">Many of these molecules (e.g., M4 and M20) would not be suitable starting points for a drug discovery campaign, highlighting the imperfections of docking as a sole oracle function.</s><s xml:id="_qpAUcPx">Docking scores to targets EGFR and IGF1R and off-target CYP3A4 were calculated with the AutoDock Vina wrapper DOCKSTRING.<ref type="bibr" target="#b83">84</ref></s></p></div></figDesc><graphic coords="8,84.70,435.97,425.95,234.82" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2</head><label>2</label><figDesc><div><p xml:id="_dcsTCF8"><s xml:id="_vNP7DuR">Performance metrics after acquisition of 10% of the library.</s><s xml:id="_zYjF7Wx">Means and standard deviation across three trials are shown.</s><s xml:id="_SXEUkhz">Metrics include hypervolume (HV) and inverted generational distance (IGD), as well as the fraction of the library's top 0.12% (4829 molecules), top 0.524% (21 015 molecules), and Pareto front points (39 molecules) acquired</s></p></div></figDesc><table><row><cell>Acquisition</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Fraction of true</cell></row><row><cell>function</cell><cell>Top ∼0.1% [</cell><cell>Top ∼0.5% [</cell><cell>HV [</cell><cell>IGD Y</cell><cell>front [</cell></row><row><cell>PHI</cell><cell>0.65 AE 0.06</cell><cell>0.50 AE 0.09</cell><cell>1.00 AE 0.00</cell><cell>0.00 AE 0.00</cell><cell>1.00 AE 0.00</cell></row><row><cell>Random</cell><cell>0.10 AE 0.00</cell><cell>0.10 AE 0.00</cell><cell>0.81 AE 0.05</cell><cell>0.88 AE 0.04</cell><cell>0.10 AE 0.04</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_azYDuh6"><s xml:id="_wHwG7E2">© 2024 The Author(s).</s><s xml:id="_kxD3qXG">Published by the Royal Society of Chemistry</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_kJeJ2S5"><s xml:id="_UABkzue">© 2024 The Author(s).</s><s xml:id="_eydUKAZ">Published by the Royal Society of Chemistry Digital Discovery, 2024, 3, 467-481 | 471</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_2"><p xml:id="_edJa8HJ"><s xml:id="_rPbZWAh">© 2024 The Author(s).</s><s xml:id="_KR8CtWR">Published by the Royal Society of Chemistry Digital Discovery, 2024, 3, 467-481 | 481</s></p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head xml:id="_v3s2nJa">Acknowledgements</head><p xml:id="_yRVDfcd"><s xml:id="_b9TKYF2">This work was funded by the <rs type="programName">DARPA Accelerated Molecular Discovery program</rs> under contract number <rs type="grantNumber">HR00111920025</rs>.</s><s xml:id="_MENwVEh">J. C. F. received additional support from the <rs type="funder">National Science Foundation Graduate Research Fellowship</rs> under Grant No. <rs type="grantNumber">2141064</rs>.</s><s xml:id="_vv9rexE">The authors acknowledge the MIT SuperCloud, <ref type="bibr" target="#b121">123</ref> Lincoln Laboratory Supercomputing Center, and the <rs type="institution">MIT Engaging Cluster</rs> for providing HPC resources that have contributed to the research results reported within this paper.</s><s xml:id="_VVauqJF">The authors thank <rs type="person">Samuel Goldman</rs> for helpful discussions about the content of this manuscript.</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_uPwmjmg">
					<idno type="grant-number">HR00111920025</idno>
					<orgName type="program" subtype="full">DARPA Accelerated Molecular Discovery program</orgName>
				</org>
				<org type="funding" xml:id="_bXzbqaf">
					<idno type="grant-number">2141064</idno>
				</org>
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_quppeMv">Data availability</head><p xml:id="_ehT7agE"><s xml:id="_xuHUa3z">The developed open source tool and all code required to reproduce the reported results can be found in the branch of MolPAL at <ref type="url" target="https://github.com/coleygroup/molpal/tree/multiobj">https://github.com/coleygroup/molpal/tree/multiobj</ref>.</s><s xml:id="_qkyVwjC">Docking scores from the DOCKSTRING benchmark are available at https://gshare.com/articles/dataset/dockstring_dataset/</s><s xml:id="_S7fsM88">16511577.</s><s xml:id="_au5cyHP">Docking scores for IGF1R, EGFR, and CYP3A4 computed as a part of this work can be found at https:// gshare.com/articles/dataset/</s><s xml:id="_DBeXz8G">Enamine_screen_CYP3A4_EGFR_IGF1R_zip/23978547.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Y6Q9xW2">Author contributions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2STq8j4">Conflicts of interest</head><p xml:id="_8mfdZhH"><s xml:id="_ftPUfxC">There are no conicts to declare.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_D9czzBg">Principles of Early Drug Discovery</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kalindjian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Philpott</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1476-5381.2010.01127.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qJQJUMu">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="1239" to="1249" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Hughes, S. Rees, S. Kalindjian and K. Philpott, Principles of Early Drug Discovery, Br. J. Pharmacol., 2011, 162, 1239- 1249.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_buZFN9m">Standing on the Shoulders of Giants: A Retrospective Analysis of Kinase Drug Discovery at Astrazeneca</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Kettle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MPr6VpR">Drug Discovery Today</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1596" to="1608" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. G. Kettle and D. M. Wilson, Standing on the Shoulders of Giants: A Retrospective Analysis of Kinase Drug Discovery at Astrazeneca, Drug Discovery Today, 2016, 21, 1596-1608.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_RRUXv4H">25 Years of Small-Molecule Optimization at Novartis: A Retrospective Analysis of Chemical Series Evolution</title>
		<author>
			<persName><forename type="first">M</forename><surname>Beckers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fechner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fmQbrg8">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="6002" to="6021" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Beckers, N. Fechner and N. Stie, 25 Years of Small- Molecule Optimization at Novartis: A Retrospective Analysis of Chemical Series Evolution, J. Chem. Inf. Model., 2022, 62, 6002-6021.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_8Qp89dX">Hit Discovery and Hit-to-Lead Approaches</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Keser}</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Makara</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.drudis.2006.06.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AbEs6z7">Drug Discovery Today</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="741" to="748" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">G. M. Keser} u and G. M. Makara, Hit Discovery and Hit-to- Lead Approaches, Drug Discovery Today, 2006, 11, 741-748.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_bE8GX48">Why 90% of Clinical Drug Development Fails and How to Improve It?</title>
		<author>
			<persName><forename type="first">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.apsb.2022.02.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_asgrp7Z">Acta Pharm. Sin. B</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="3049" to="3062" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. Sun, W. Gao, H. Hu and S. Zhou, Why 90% of Clinical Drug Development Fails and How to Improve It?, Acta Pharm. Sin. B, 2022, 12, 3049-3062.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_yssj5nB">Addressing Toxicity Risk When Designing and Selecting Compounds in Early Drug Discovery</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Segall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TEhMHGB">Drug Discovery Today</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="688" to="693" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. D. Segall and C. Barber, Addressing Toxicity Risk When Designing and Selecting Compounds in Early Drug Discovery, Drug Discovery Today, 2014, 19, 688-693.</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_UbAFB6C">Screening Strategies and Methods for Better Off-Target Liability Prediction and Identication of Small-Molecule Pharmaceuticals</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Van Vleet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Liguori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>James</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Warder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_E29v7QJ">SLAS Discovery</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1" to="24" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. R. Van Vleet, M. J. Liguori, I. Lynch, J. James, M. Rao and S. Warder, Screening Strategies and Methods for Better Off- Target Liability Prediction and Identication of Small- Molecule Pharmaceuticals, SLAS Discovery, 2019, 24, 1-24.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_6cQb8Z6">Hit and Lead Generation: Beyond High-Throughput Screening</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Bleicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-J</forename><surname>Böhm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Alanine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9XJ2kVb">Nat. Rev. Drug Discovery</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="369" to="378" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. H. Bleicher, H.-J. Böhm, K. Müller and A. I. Alanine, Hit and Lead Generation: Beyond High-Throughput Screening, Nat. Rev. Drug Discovery, 2003, 2, 369-378.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_bjgMGvk">Silico Antitarget Screening</title>
		<author>
			<persName><forename type="first">M</forename><surname>Recanatini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bottegoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cavalli</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ddtec.2004.10.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SSbWgRs">Drug Discovery Today: Technol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="209" to="215" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Recanatini, G. Bottegoni and A. Cavalli, Silico Antitarget Screening, Drug Discovery Today: Technol., 2004, 1, 209-215.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_n4REdVh">Ligand Selectivity and Competition Between Enzymes in Silico</title>
		<author>
			<persName><forename type="first">A</forename><surname>Macchiarulo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nobeli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Thornton</surname></persName>
		</author>
		<idno type="DOI">10.1038/nbt999</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4UFhTwS">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1039" to="1045" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Macchiarulo, I. Nobeli and J. M. Thornton, Ligand Selectivity and Competition Between Enzymes in Silico, Nat. Biotechnol., 2004, 22, 1039-1045.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_5sjwajV">Dual or Multi-Targeting Inhibitors: The Next Generation Anticancer Agents</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Raghavendra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pingili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kadasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mettu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V U M</forename><surname>Prasad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AcvMeDt">Eur. J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1277" to="1300" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. M. Raghavendra, D. Pingili, S. Kadasi, A. Mettu and S. V. U. M. Prasad, Dual or Multi-Targeting Inhibitors: The Next Generation Anticancer Agents, Eur. J. Med. Chem., 2018, 143, 1277-1300.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_QUN55wG">Multitarget Therapeutic Strategies for Alzheimer&apos;s Disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Gabr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sPG5KuD">Neural Regener. Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="437" to="440" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. M. Ibrahim and M. T. Gabr, Multitarget Therapeutic Strategies for Alzheimer&apos;s Disease, Neural Regener. Res., 2019, 14, 437-440.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_Gf7DQQS">A Perspective on Multi-target Drugs for Alzheimer&apos;s Disease</title>
		<author>
			<persName><forename type="first">O</forename><surname>Benek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Korabecny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Soukup</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Uj5NefQ">Trends Pharmacol. Sci</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="434" to="445" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">O. Benek, J. Korabecny and O. Soukup, A Perspective on Multi-target Drugs for Alzheimer&apos;s Disease, Trends Pharmacol. Sci., 2020, 41, 434-445.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_aknP9YJ">Role of Vandetanib in the Management of Medullary Thyroid Cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Brassard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rondeau</surname></persName>
		</author>
		<idno type="DOI">10.2147/btt.s24220</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fur2Era">Biol.: Targets Ther</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="59" to="66" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Brassard and G. Rondeau, Role of Vandetanib in the Management of Medullary Thyroid Cancer, Biol.: Targets Ther., 2012, 6, 59-66.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_T62GqV2">Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization</title>
		<author>
			<persName><forename type="first">K</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ikemori-Kawada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jestel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>König</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Funahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Matsushima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tsuruoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Matsui</surname></persName>
		</author>
		<idno type="DOI">10.1021/ml500394m</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_h5yxh8M">ACS Med. Chem. Lett</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="89" to="94" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Okamoto, M. Ikemori-Kawada, A. Jestel, K. von König, Y. Funahashi, T. Matsushima, A. Tsuruoka, A. Inoue and J. Matsui, Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization, ACS Med. Chem. Lett., 2015, 6, 89-94.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_As69Rxh">In-Silico Approaches to Multi-target Drug Discovery</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">H</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Go</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Z</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11095-010-0065-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9gK5DXB">Pharm. Res</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="739" to="749" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">X. H. Ma, Z. Shi, C. Tan, Y. Jiang, M. L. Go, B. C. Low and Y. Z. Chen, In-Silico Approaches to Multi-target Drug Discovery, Pharm. Res., 2010, 27, 739-749.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_ajkT3W5">Structure-Based Virtual Screening and Molecular Docking for the Identication of Potential Multi-Targeted Inhibitors Against Breast Cancer</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yousuf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Iman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Iikhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">U</forename><surname>Mirza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vYCvehh">Breast Cancer: Targets Ther</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="447" to="459" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Z. Yousuf, K. Iman, N. Iikhar and M. U. Mirza, Structure- Based Virtual Screening and Molecular Docking for the Identication of Potential Multi-Targeted Inhibitors Against Breast Cancer, Breast Cancer: Targets Ther., 2017, 9, 447-459.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_PvgJb8P">A Combination Strategy of Structure-Based Virtual Screening, MM-GBSA, Cross Docking, Molecular Dynamics and Metadynamics Simulations Used to Investigate Natural Compounds as Potent and Specic Inhibitors of Tumor Linked Human Carbonic Anhydrase Ix</title>
		<author>
			<persName><forename type="first">V</forename><surname>Chahal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kakkar</surname></persName>
		</author>
		<idno type="DOI">10.1080/07391102.2022.2087736</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CvFepha">J. Biomol. Struct. Dyn</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="5465" to="5480" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">V. Chahal and R. Kakkar, A Combination Strategy of Structure-Based Virtual Screening, MM-GBSA, Cross Docking, Molecular Dynamics and Metadynamics Simulations Used to Investigate Natural Compounds as Potent and Specic Inhibitors of Tumor Linked Human Carbonic Anhydrase Ix, J. Biomol. Struct. Dyn., 2023, 41, 5465-5480.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_RKphnFW">Development of Pharmacophore Models for the Important Off-Target 5-HT2B Receptor</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schieferdecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7TzXDR5">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1509" to="1521" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Schieferdecker and E. Vock, Development of Pharmacophore Models for the Important Off-Target 5- HT2B Receptor, J. Med. Chem., 2023, 66, 1509-1521.</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_8qSsUUm">Structure-Based Virtual Screening Discovers Potent and Selective Adenosine A1 Receptor Antagonists</title>
		<author>
			<persName><forename type="first">P</forename><surname>Matricon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Vo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-A</forename><surname>Baltos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jaiteh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luttens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kampen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Christopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kihlberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>May</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carlsson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejmech.2023.115419</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EWYffav">Eur. J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">257</biblScope>
			<biblScope unit="page">115419</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. Matricon, A. T. Nguyen, D. D. Vo, J.-A. Baltos, M. Jaiteh, A. Luttens, S. Kampen, A. Christopoulos, J. Kihlberg, L. T. May and J. Carlsson, Structure-Based Virtual Screening Discovers Potent and Selective Adenosine A1 Receptor Antagonists, Eur. J. Med. Chem., 2023, 257, 115419.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_reyTcFP">Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Karpiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-P</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Sassano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jmedchem.8b00718</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fka29mk">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="6830" to="6845" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. R. Weiss, J. Karpiak, X.-P. Huang, M. F. Sassano, J. Lyu, B. L. Roth and B. K. Shoichet, Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets, J. Med. Chem., 2018, 61, 6830-6845.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_87BMK3n">On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Lyne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Giordanetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lovell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5MJeVYx">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="401" to="415" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">H. Chen, P. D. Lyne, F. Giordanetto, T. Lovell and J. Li, On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors, J. Chem. Inf. Model., 2006, 46, 401- 415.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_cExkeeN">Bias, Reporting, and Sharing: Computational Evaluations of Docking Methods</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Jain</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10822-007-9151-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_234jQ7K">J. Comput.-Aided Mol. Des</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="201" to="212" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. N. Jain, Bias, Reporting, and Sharing: Computational Evaluations of Docking Methods, J. Comput.-Aided Mol. Des., 2008, 22, 201-212.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_rB97M3W">Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Rai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Baber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Humblet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6K2Ug7q">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="1455" to="1474" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. B. Cross, D. C. Thompson, B. K. Rai, J. C. Baber, K. Y. Fan, Y. Hu and C. Humblet, Comparison of Several Molecular Docking Programs: Pose Prediction and Virtual Screening Accuracy, J. Chem. Inf. Model., 2009, 49, 1455-1474.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_wmu7erB">Docking Screens for Novel Ligands Conferring New Biology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Irwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qWqXdwp">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="4103" to="4120" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. J. Irwin and B. K. Shoichet, Docking Screens for Novel Ligands Conferring New Biology, J. Med. Chem., 2016, 59, 4103-4120.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_uzsVRRW">Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Boittier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">P</forename><surname>Schuurs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Richard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Gandhi</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms21155183</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r9SNRfp">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">5183</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. D. Boittier, Y. Y. Tang, M. E. Buckley, Z. P. Schuurs, D. J. Richard and N. S. Gandhi, Assessing Molecular Docking Tools to Guide Targeted Drug Discovery of CD38 Inhibitors, Int. J. Mol. Sci., 2020, 21, 5183.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<author>
			<persName><forename type="first">F</forename><surname>Stanzione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Giangreco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cole</surname></persName>
		</author>
		<title level="m" xml:id="_3CH5rEZ">Progress in Medicinal Chemistry</title>
		<editor>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Witty</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">B</forename><surname>Cox</surname></persName>
		</editor>
		<imprint>
			<publisher>Elsevier</publisher>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="273" to="343" />
		</imprint>
	</monogr>
	<note type="raw_reference">F. Stanzione, I. Giangreco and J. C. Cole, Progress in Medicinal Chemistry, ed. D. R. Witty and B. Cox, Elsevier, 2021, vol. 60, pp. 273-343.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_CB2pau2">Transforming Growth Factor-b in Cancer Therapy, Volume II: Cancer Treatment and Therapy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Ling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_fvvb2UB">Cancer Drug Discovery and Development</title>
		<editor>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Jakowlew</surname></persName>
		</editor>
		<meeting><address><addrLine>Totowa, NJ</addrLine></address></meeting>
		<imprint>
			<publisher>Humana Press</publisher>
			<date type="published" when="2008">2008</date>
			<biblScope unit="page" from="685" to="696" />
		</imprint>
	</monogr>
	<note type="raw_reference">L. E. Ling and et al., Transforming Growth Factor-b in Cancer Therapy, Volume II: Cancer Treatment and Therapy, ed. S. B. Jakowlew, Cancer Drug Discovery and Development, Humana Press, Totowa, NJ, 2008, pp. 685-696.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_Mg2g6vU">Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening</title>
		<author>
			<persName><forename type="first">D</forename><surname>Bajusz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Ferenczy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Keser}</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Gudkyzh">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="234" to="247" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. Bajusz, G. G. Ferenczy and G. M. Keser} u, Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening, J. Chem. Inf. Model., 2016, 56, 234-247.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_vuvxFQg">Ultra-Large Library Docking for Discovering New Chemotypes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Balius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Levit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Moroz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>O'meara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Che</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Algaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tolmachova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Tolmachev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Irwin</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41586-019-0917-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8VGUC5S">Nature</title>
		<imprint>
			<biblScope unit="volume">566</biblScope>
			<biblScope unit="page" from="224" to="229" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Lyu, S. Wang, T. E. Balius, I. Singh, A. Levit, Y. S. Moroz, M. J. O&apos;Meara, T. Che, E. Algaa, K. Tolmachova, A. A. Tolmachev, B. K. Shoichet, B. L. Roth and J. J. Irwin, Ultra-Large Library Docking for Discovering New Chemotypes, Nature, 2019, 566, 224-229.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_ucz5KF7">Automated Discovery of Noncovalent Inhibitors of Sars-Cov-2 Main Protease by Consensus Deep Docking of 40 Billion Small Molecules</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-T</forename><surname>Ton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mslati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Leblanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Yaacoub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gleave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Strynadka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cherkasov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eXCwJdN">Chem. Sci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="15960" to="15974" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Gentile, M. Fernandez, F. Ban, A.-T. Ton, H. Mslati, C. F. Perez, E. Leblanc, J. C. Yaacoub, J. Gleave, A. Stern, B. Wong, F. Jean, N. Strynadka and A. Cherkasov, Automated Discovery of Noncovalent Inhibitors of Sars- Cov-2 Main Protease by Consensus Deep Docking of 40 Billion Small Molecules, Chem. Sci., 2021, 12, 15960-15974.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_vubY5PR">Structures of the s 2 Receptor Enable Docking for Bioactive Ligand Discovery</title>
		<author>
			<persName><forename type="first">A</forename><surname>Alon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UUyYNAC">Nature</title>
		<imprint>
			<biblScope unit="volume">600</biblScope>
			<biblScope unit="page" from="759" to="764" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Alon, et al., Structures of the s 2 Receptor Enable Docking for Bioactive Ligand Discovery, Nature, 2021, 600, 759-764.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_5bzHeVV">Large-Scale Docking in the Cloud</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Tingle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Irwin</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jcim.3c00031</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PRK3qwW">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2735" to="2741" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">B. I. Tingle and J. J. Irwin, Large-Scale Docking in the Cloud, J. Chem. Inf. Model., 2023, 63, 2735-2741.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_W6KHsjj">Introducing the &apos;Active Search&apos; Method for Iterative Virtual Screening</title>
		<author>
			<persName><forename type="first">R</forename><surname>Garnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gärtner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bajorath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_trEEjg8">J. Comput.-Aided Mol. Des</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="305" to="314" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. Garnett, T. Gärtner, M. Vogt and J. Bajorath, Introducing the &apos;Active Search&apos; Method for Iterative Virtual Screening, J. Comput.-Aided Mol. Des., 2015, 29, 305-314.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_SAN4zdr">Less Is More: Sampling Chemical Space with Active Learning</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nebgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lubbers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Isayev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Roitberg</surname></persName>
		</author>
		<idno type="DOI">10.1063/1.5023802</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_y7vT9EJ">J. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page">241733</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. S. Smith, B. Nebgen, N. Lubbers, O. Isayev and A. E. Roitberg, Less Is More: Sampling Chemical Space with Active Learning, J. Chem. Phys., 2018, 148, 241733.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_rWyEKjU">Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery</title>
		<author>
			<persName><forename type="first">F</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hsing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A.-T</forename><surname>Ton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Norinder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Gleave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cherkasov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u94nGKb">ACS Cent. Sci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="939" to="949" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Gentile, V. Agrawal, M. Hsing, A.-T. Ton, F. Ban, U. Norinder, M. E. Gleave and A. Cherkasov, Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery, ACS Cent. Sci., 2020, 6, 939-949.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_qJEr2Gb">Accelerating High-Throughput Virtual Screening Through Molecular Pool-Based Active Learning</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Graff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Shakhnovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Coley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jaEAm9b">Chem. Sci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="7866" to="7881" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. E. Graff, E. I. Shakhnovich and C. W. Coley, Accelerating High-Throughput Virtual Screening Through Molecular Pool-Based Active Learning, Chem. Sci., 2021, 12, 7866- 7881.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_H6f8BNK">Efficient Exploration of Chemical Space with Docking and Deep Learning</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Repasky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Leswing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Abel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Jerome</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jctc.1c00810</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_raJeSdR">J. Chem. Theory Comput</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="7106" to="7119" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Yang, K. Yao, M. P. Repasky, K. Leswing, R. Abel, B. K. Shoichet and S. V. Jerome, Efficient Exploration of Chemical Space with Docking and Deep Learning, J. Chem. Theory Comput., 2021, 17, 7106-7119.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_ktPMQhv">MEMES: Machine Learning Framework for Enhanced Molecular Screening</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Laghuvarapu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pathak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sethi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alvala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">D</forename><surname>Priyakumar</surname></persName>
		</author>
		<idno type="DOI">10.1039/d1sc02783b</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_saJkKM8">Chem. Sci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="11710" to="11721" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Mehta, S. Laghuvarapu, Y. Pathak, A. Sethi, M. Alvala and U. D. Priyakumar, MEMES: Machine Learning Framework for Enhanced Molecular Screening, Chem. Sci., 2021, 12, 11710-11721.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_p6ZK6ND">Self-Focusing Virtual Screening with Active Design Space Pruning</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Graff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aldeghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Morrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Jordan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Pyzer-Knapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Coley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5bfWxu3">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="3854" to="3862" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. E. Graff, M. Aldeghi, J. A. Morrone, K. E. Jordan, E. O. Pyzer-Knapp and C. W. Coley, Self-Focusing Virtual Screening with Active Design Space Pruning, J. Chem. Inf. Model., 2022, 62, 3854-3862.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_3qYxbg7">Optimizing Active Learning for Free Energy Calculations</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Pabon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Goldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moustakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>York</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8W4hahH">Artif. Intell. Life Sci</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">100050</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Thompson, W. P. Walters, J. A. Feng, N. A. Pabon, H. Xu, M. Maser, B. B. Goldman, D. Moustakas, M. Schmidt and F. York, Optimizing Active Learning for Free Energy Calculations, Artif. Intell. Life Sci., 2022, 2, 100050.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_KFnUjjD">MO-MEMES: A Method for Accelerating Virtual Screening Using Multi-Objective Bayesian Optimization</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">D</forename><surname>Priyakumar</surname></persName>
		</author>
		<idno type="DOI">10.3389/fmed.2022.916481</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MrZCUyv">Front. Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. Mehta, M. Goel and U. D. Priyakumar, MO-MEMES: A Method for Accelerating Virtual Screening Using Multi- Objective Bayesian Optimization, Front. Med., 2022, 9, DOI: 10.3389/fmed.2022.916481.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_67vJnrk">Prediction of Physicochemical Parameters by Atomic Contributions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Wildman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Crippen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b8FvKZd">J. Chem. Inf. Comput. Sci</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="868" to="873" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. A. Wildman and G. M. Crippen, Prediction of Physicochemical Parameters by Atomic Contributions, J. Chem. Inf. Comput. Sci., 1999, 39, 868-873.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_S35d4ah">Estimation of Synthetic Accessibility Score of Drug-like Molecules Based on Molecular Complexity and Fragment Contributions</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ertl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schuffenhauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uekdZSa">J. Cheminf</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">8</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">P. Ertl and A. Schuffenhauer, Estimation of Synthetic Accessibility Score of Drug-like Molecules Based on Molecular Complexity and Fragment Contributions, J. Cheminf., 2009, 1, 8.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<ptr target="https://enamine.net/compound-collections/screening-collection" />
		<title level="m" xml:id="_JAyDyhU">Enamine Screening Collections</title>
		<imprint>
			<date type="published" when="2023-05">May 2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Enamine Screening Collections, https://enamine.net/ compound-collections/screening-collection, downloaded May 2023.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_v22DAJw">Computer-Aided Multi-Objective Optimization in Small Molecule Discovery</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Fromer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Coley</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.patter.2023.100678</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GaBaGcr">Patterns</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">100678</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. C. Fromer and C. W. Coley, Computer-Aided Multi- Objective Optimization in Small Molecule Discovery, Patterns, 2023, 4, 100678.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_whSC3uj">Accurate Multiobjective Design in a Space of Millions of Transition Metal Complexes with Neural-Network-Driven Efficient Global Optimization</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Janet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ramesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kulik</surname></persName>
		</author>
		<idno type="DOI">10.1021/acscentsci.0c00026</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4bBuQhq">ACS Cent. Sci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="513" to="524" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. P. Janet, S. Ramesh, C. Duan and H. J. Kulik, Accurate Multiobjective Design in a Space of Millions of Transition Metal Complexes with Neural-Network-Driven Efficient Global Optimization, ACS Cent. Sci., 2020, 6, 513-524.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_5NkZKxF">Discovery of Energy Storage Molecular Materials Using Quantum Chemistry-Guided Multiobjective Bayesian Optimization</title>
		<author>
			<persName><forename type="first">G</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Doan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Assary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XV27fxZ">Chem. Mater</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="8133" to="8144" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">G. Agarwal, H. A. Doan, L. A. Robertson, L. Zhang and R. S. Assary, Discovery of Energy Storage Molecular Materials Using Quantum Chemistry-Guided Multiobjective Bayesian Optimization, Chem. Mater., 2021, 33, 8133-8144.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_afybyUs">Multiobjective Solid Electrolyte Design of Tetragonal and Cubic Inverse-Perovskites for All-Solid-State Lithium-Ion Batteries by High-Throughput Density Functional Theory Calculations and AI-Driven Methods</title>
		<author>
			<persName><forename type="first">R</forename><surname>Jalem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tateyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Takada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Jang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hYKkUkc">J. Phys. Chem. C</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="17307" to="17323" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. Jalem, Y. Tateyama, K. Takada and S.-H. Jang, Multiobjective Solid Electrolyte Design of Tetragonal and Cubic Inverse-Perovskites for All-Solid-State Lithium-Ion Batteries by High-Throughput Density Functional Theory Calculations and AI-Driven Methods, J. Phys. Chem. C, 2023, 127, 17307-17323.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_t483usb">Multi-objective Optimization for Materials Discovery via Adaptive Design</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gopakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Balachandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Gubernatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lookman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Z5GVkwF">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">3738</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. M. Gopakumar, P. V. Balachandran, D. Xue, J. E. Gubernatis and T. Lookman, Multi-objective Optimization for Materials Discovery via Adaptive Design, Sci. Rep., 2018, 8, 3738.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_fS2VUZ9">Assessing the Frontier: Active Learning, Model Accuracy, and Multi-Objective Candidate Discovery and Optimization</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Del Rosario</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Antono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ling</surname></persName>
		</author>
		<idno type="DOI">10.1063/5.0006124</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KDaNuAH">J. Chem. Phys</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page">24112</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Z. del Rosario, M. Rupp, Y. Kim, E. Antono and J. Ling, Assessing the Frontier: Active Learning, Model Accuracy, and Multi-Objective Candidate Discovery and Optimization, J. Chem. Phys., 2020, 153, 024112.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_f5tvFfh">Design of Antimicrobial Peptides Containing Non-Proteinogenic Amino Acids Using Multi-Objective Bayesian Optimisation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Demizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Terayama</surname></persName>
		</author>
		<idno type="DOI">10.1039/d3dd00090g</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UFDajMt">Digital Discovery</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1347" to="1353" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Murakami, S. Ishida, Y. Demizu and K. Terayama, Design of Antimicrobial Peptides Containing Non-Proteinogenic Amino Acids Using Multi-Objective Bayesian Optimisation, Digital Discovery, 2023, 2, 1347-1353.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_U7v3gjc">Improvement Criteria for Use in Multiobjective Design Optimization</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J S</forename><surname>Keane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_34Jb2ax">AIAA J</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="879" to="891" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. J. S. Keane, Improvement Criteria for Use in Multiobjective Design Optimization, AIAA J., 2006, 44, 879-891.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_Ru8FftA">A Flexible Framework for Multi-Objective Bayesian Optimization using Random Scalarizations</title>
		<author>
			<persName><forename type="first">B</forename><surname>Paria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kandasamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Póczos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_ksjq9uQ">Proceedings of The 35th Uncertainty in Articial Intelligence Conference</title>
		<meeting>The 35th Uncertainty in Articial Intelligence Conference</meeting>
		<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="page" from="766" to="776" />
		</imprint>
	</monogr>
	<note type="raw_reference">B. Paria, K. Kandasamy and B. Póczos, A Flexible Framework for Multi-Objective Bayesian Optimization using Random Scalarizations, Proceedings of The 35th Uncertainty in Articial Intelligence Conference. 2020, pp. 766-776.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_ZXtMySS">Random Hypervolume Scalarizations for Provable Multi-Objective Black Box Optimization</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Golovin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_KzGtMZA">Proceedings of the 37th International Conference on Machine Learning</title>
		<meeting>the 37th International Conference on Machine Learning</meeting>
		<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="page" from="11096" to="11105" />
		</imprint>
	</monogr>
	<note type="raw_reference">R. Zhang and D. Golovin, Random Hypervolume Scalarizations for Provable Multi-Objective Black Box Optimization, Proceedings of the 37th International Conference on Machine Learning, 2020, pp. 11096-11105.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_dvtm3cZ">An Interactive Weighted Tchebycheff Procedure for Multiple Objective Programming</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Steuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E.-U</forename><surname>Choo</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf02591870</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4GFRPen">Math. Program</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="326" to="344" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. E. Steuer and E.-U. Choo, An Interactive Weighted Tchebycheff Procedure for Multiple Objective Programming, Math. Program., 1983, 26, 326-344.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_5GvcVNu">Methods for Multi-Objective Optimization: An Analysis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Giagkiozis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fleming</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ins.2014.08.071</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ayxEGW2">Inf. Sci</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="338" to="350" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">I. Giagkiozis and P. J. Fleming, Methods for Multi-Objective Optimization: An Analysis, Inf. Sci., 2015, 293, 338-350.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_VQ7Zm6G">New Method of Locating the Maximum Point of an Arbitrary Multipeak Curve in the Presence of Noise</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J A</forename><surname>Kushner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ygrzfpN">J. Basic Eng</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="97" to="106" />
			<date type="published" when="1964">1964</date>
		</imprint>
	</monogr>
	<note type="raw_reference">H. J. A. Kushner, New Method of Locating the Maximum Point of an Arbitrary Multipeak Curve in the Presence of Noise, J. Basic Eng., 1964, 86, 97-106.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_9FbsbMG">On Bayesian Methods for Seeking the Extremum</title>
		<author>
			<persName><forename type="first">J</forename><surname>Močkus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_6KmuRQa">Optimization Techniques IFIP Technical Conference Novosibirsk</title>
		<meeting><address><addrLine>Berlin, Heidelberg</addrLine></address></meeting>
		<imprint>
			<date type="published" when="1974">July 1-7, 1974. 1975</date>
			<biblScope unit="page" from="400" to="404" />
		</imprint>
	</monogr>
	<note type="raw_reference">J. Močkus, On Bayesian Methods for Seeking the Extremum. Optimization Techniques IFIP Technical Conference Novosibirsk, July 1-7, 1974, Berlin, Heidelberg, 1975, pp. 400-404.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_yhJq6Yn">Information-Theoretic Regret Bounds for Gaussian Process Optimization in the Bandit Setting</title>
		<author>
			<persName><forename type="first">N</forename><surname>Srinivas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kakade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Seeger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PWysQcb">IEEE Trans. Inf. Theory</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="3250" to="3265" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. Srinivas, A. Krause, S. M. Kakade and M. W. Seeger, Information-Theoretic Regret Bounds for Gaussian Process Optimization in the Bandit Setting, IEEE Trans. Inf. Theory, 2012, 58, 3250-3265.</note>
</biblStruct>

<biblStruct xml:id="b60">
	<monogr>
		<title level="m" type="main" xml:id="_yCJEDWF">Directions in Large-Scale Systems: Many-Person Optimization and Decentralized Control</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Lin</surname></persName>
		</author>
		<editor>Y. C. Ho and S. K. Mitter</editor>
		<imprint>
			<date type="published" when="1976">1976</date>
			<publisher>Springer US</publisher>
			<biblScope unit="page" from="117" to="138" />
			<pubPlace>Boston, MA</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">J. G. Lin, Directions in Large-Scale Systems: Many-Person Optimization and Decentralized Control, ed. Y. C. Ho and S. K. Mitter, Springer US, Boston, MA, 1976, pp. 117-138.</note>
</biblStruct>

<biblStruct xml:id="b61">
	<monogr>
		<title level="m" type="main" xml:id="_9Z8Td3U">Revisiting Scalarization in Multi-Task Learning: A Theoretical Perspective</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Xian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhao</surname></persName>
		</author>
		<ptr target="http://arxiv.org/abs/2308.13985" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Hu, R. Xian, Q. Wu, Q. Fan, L. Yin and H. Zhao, Revisiting Scalarization in Multi-Task Learning: A Theoretical Perspective, 2023, http://arxiv.org/abs/2308.13985.</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_7MyPgSS">Muiltiobjective Optimization Using Nondominated Sorting in Genetic Algorithms</title>
		<author>
			<persName><forename type="first">N</forename><surname>Srinivas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Deb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MnpVuZk">Evol Comput</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="221" to="248" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. Srinivas and K. Deb, Muiltiobjective Optimization Using Nondominated Sorting in Genetic Algorithms, Evol Comput., 1994, 2, 221-248.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_JM8GSGm">A Fast and Elitist Multiobjective Genetic Algorithm: NSGA-II</title>
		<author>
			<persName><forename type="first">K</forename><surname>Deb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pratap</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meyarivan</surname></persName>
		</author>
		<idno type="DOI">10.1109/4235.996017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U3uHXDF">IEEE Trans. Evol. Comput</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="182" to="197" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Deb, A. Pratap, S. Agarwal and T. Meyarivan, A Fast and Elitist Multiobjective Genetic Algorithm: NSGA-II, IEEE Trans. Evol. Comput., 2002, 6, 182-197.</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_QWvp82K">Designing Multi-Objective Multi-Armed Bandits Algorithms: A Study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Drugan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nowe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_umxe9Qt">The 2013 International Joint Conference on Neural Networks, IJCNN</title>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="page" from="1" to="8" />
		</imprint>
	</monogr>
	<note type="raw_reference">M. M. Drugan and A. Nowe, Designing Multi-Objective Multi- Armed Bandits Algorithms: A Study. The 2013 International Joint Conference on Neural Networks, IJCNN, 2013, pp. 1-8.</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_GnSEtSd">A Comparison of Loss Weighting Strategies for Multi task Learning in Deep Neural Networks</title>
		<author>
			<persName><forename type="first">T</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stephenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Renduchintala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Padhy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ndirango</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Keskin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">H</forename><surname>Elibol</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ADcb8ct">IEEE Access</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="141627" to="141632" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. Gong, T. Lee, C. Stephenson, V. Renduchintala, S. Padhy, A. Ndirango, G. Keskin and O. H. Elibol, A Comparison of Loss Weighting Strategies for Multi task Learning in Deep Neural Networks, IEEE Access, 2019, 7, 141627-141632.</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_ex7TJ5g">Batched Bayesian Optimization for Drug Design in Noisy Environments</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bellamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Rehim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">I</forename><surname>Orhobor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>King</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_75NJF3c">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="3970" to="3981" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">H. Bellamy, A. A. Rehim, O. I. Orhobor and R. King, Batched Bayesian Optimization for Drug Design in Noisy Environments, J. Chem. Inf. Model., 2022, 62, 3970-3981.</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_SZxwqAV">Computational Intelligence in Expensive Optimization Problems</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ginsbourger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Le Riche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Carraro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_H7B5gjH">Adaptation Learning and Optimization</title>
		<editor>
			<persName><forename type="first">Y</forename><surname>Tenne</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">C.-K</forename><surname>Goh</surname></persName>
		</editor>
		<meeting><address><addrLine>Berlin, Heidelberg</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2010">2010</date>
			<biblScope unit="page" from="131" to="162" />
		</imprint>
	</monogr>
	<note type="raw_reference">D. Ginsbourger, R. Le Riche and L. Carraro, Computational Intelligence in Expensive Optimization Problems, ed. Y. Tenne and C.-K. Goh, Adaptation Learning and Optimization, Springer, Berlin, Heidelberg, 2010, pp. 131-162.</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_bPPAaN5">Practical Bayesian Optimization of Machine Learning Algorithms</title>
		<author>
			<persName><forename type="first">J</forename><surname>Snoek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Larochelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Adams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_qj2e2WP">Advances in Neural Information Processing Systems</title>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Snoek, H. Larochelle and R. P. Adams, Practical Bayesian Optimization of Machine Learning Algorithms, Advances in Neural Information Processing Systems, 2012.</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_GNK2PTg">Expected Improvements for the Asynchronous Parallel Global Optimization of Expensive Functions: Potentials and Challenges</title>
		<author>
			<persName><forename type="first">J</forename><surname>Janusevskis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Le Riche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ginsbourger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Girdziusas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_ahD5cJq">Learning and Intelligent Optimization</title>
		<meeting><address><addrLine>Berlin, Heidelberg</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="page" from="413" to="418" />
		</imprint>
	</monogr>
	<note type="raw_reference">J. Janusevskis, R. Le Riche, D. Ginsbourger and R. Girdziusas, Expected Improvements for the Asynchronous Parallel Global Optimization of Expensive Functions: Potentials and Challenges. Learning and Intelligent Optimization, Berlin, Heidelberg, 2012, pp. 413-418.</note>
</biblStruct>

<biblStruct xml:id="b70">
	<monogr>
		<title level="m" type="main" xml:id="_3r3ruVX">Fast Computation of the Multi-Points Expected Improvement with Applications in Batch Selection, Learning and Intelligent Optimization</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chevalier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ginsbourger</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="page" from="59" to="69" />
			<pubPlace>Berlin, Heidelberg</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">C. Chevalier and D. Ginsbourger, Fast Computation of the Multi-Points Expected Improvement with Applications in Batch Selection, Learning and Intelligent Optimization, Berlin, Heidelberg, 2013, pp. 59-69.</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_RfejMDc">Efficient Nonmyopic Active Search</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Malkomes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Converse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shofner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Garnett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_V5ezuMH">Proceedings of the 34th International Conference on Machine Learning</title>
		<meeting>the 34th International Conference on Machine Learning</meeting>
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="page" from="1714" to="1723" />
		</imprint>
	</monogr>
	<note type="raw_reference">S. Jiang, G. Malkomes, G. Converse, A. Shofner, B. Moseley and R. Garnett, Efficient Nonmyopic Active Search, Proceedings of the 34th International Conference on Machine Learning, 2017, pp. 1714-1723.</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_Krk7gDs">pBO-2GP-3B: A Batch Parallel Known/Unknown Constrained Bayesian Optimization with Feasibility Classication and Its Applications in Computational Fluid Dynamics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Furlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Pagalthivarthi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Visintainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4utkXaG">Comput. Methods Appl. Mech. Eng</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="page" from="827" to="852" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Tran, J. Sun, J. M. Furlan, K. V. Pagalthivarthi, R. J. Visintainer and Y. Wang, pBO-2GP-3B: A Batch Parallel Known/Unknown Constrained Bayesian Optimization with Feasibility Classication and Its Applications in Computational Fluid Dynamics, Comput. Methods Appl. Mech. Eng., 2019, 347, 827-852.</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_DFCpJxn">Batch Bayesian Optimization via Simulation Matching</title>
		<author>
			<persName><forename type="first">J</forename><surname>Azimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Fern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_FfJBrAc">Advances in Neural Information Processing Systems</title>
		<imprint>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Azimi, A. Fern and X. Fern, Batch Bayesian Optimization via Simulation Matching, Advances in Neural Information Processing Systems, 2010.</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_n5Ferae">Batch Bayesian Optimization via Local Penalization</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hennig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Lawrence</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_JkSEACB">Proceedings of the 19th International Conference on Articial Intelligence and Statistics</title>
		<meeting>the 19th International Conference on Articial Intelligence and Statistics</meeting>
		<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="page" from="648" to="657" />
		</imprint>
	</monogr>
	<note type="raw_reference">J. Gonzalez, Z. Dai, P. Hennig and N. Lawrence, Batch Bayesian Optimization via Local Penalization, Proceedings of the 19th International Conference on Articial Intelligence and Statistics, 2016, pp. 648-657.</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_a7DRzgE">Diversity-Guided Multi-Objective Bayesian Optimization With Batch Evaluations</title>
		<author>
			<persName><forename type="first">M</forename><surname>Konakovic Lukovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Matusik</surname></persName>
		</author>
		<idno type="DOI">10.2514/6.2021-1482.vid</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_q2KPZPx">Adv. Neural Inf. Process</title>
		<imprint>
			<biblScope unit="page" from="17708" to="17720" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Konakovic Lukovic, Y. Tian and W. Matusik, Diversity- Guided Multi-Objective Bayesian Optimization With Batch Evaluations, Adv. Neural Inf. Process., 2020, 17708-17720.</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_RZkfN4n">Batch Active Learning at Scale</title>
		<author>
			<persName><forename type="first">G</forename><surname>Citovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Desalvo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gentile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Karydas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rajagopalan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rostamizadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Exf9ttv">Adv. Neural Inf. Process</title>
		<imprint>
			<biblScope unit="page" from="11933" to="11944" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">G. Citovsky, G. DeSalvo, C. Gentile, L. Karydas, A. Rajagopalan, A. Rostamizadeh and S. Kumar, Batch Active Learning at Scale, Adv. Neural Inf. Process., 2021, 11933-11944.</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_RU3TU62">Discovering Many Diverse Solutions with Bayesian Optimization</title>
		<author>
			<persName><forename type="first">N</forename><surname>Maus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gardner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_wD27RGB">Proceedings of the 26th International Conference on Articial Intelligence and Statistics</title>
		<meeting>the 26th International Conference on Articial Intelligence and Statistics<address><addrLine>Valencia, Spain</addrLine></address></meeting>
		<imprint>
			<publisher>AISTATS</publisher>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. Maus, K. Wu, D. Eriksson and J. Gardner, Discovering Many Diverse Solutions with Bayesian Optimization, Proceedings of the 26th International Conference on Articial Intelligence and Statistics, AISTATS, Valencia, Spain, 2023.</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_YN3Gs4N">New Paradigms for Exploiting Parallel Experiments in Bayesian Optimization</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>González</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Zavala</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.compchemeng.2022.108110</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9KDz63e">Comput. Chem. Eng</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page">108110</biblScope>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. D. González and V. M. Zavala, New Paradigms for Exploiting Parallel Experiments in Bayesian Optimization, Comput. Chem. Eng., 2023, 170, 108110.</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_6YWEyFw">Ensemble Docking of Multiple Protein Structures: Considering Protein Structural Variations in Molecular Docking</title>
		<author>
			<persName><forename type="first">S.-Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4e8SFbZ">Proteins: Struct., Funct., Bioinf</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="399" to="421" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S.-Y. Huang and X. Zou, Ensemble Docking of Multiple Protein Structures: Considering Protein Structural Variations in Molecular Docking, Proteins: Struct., Funct., Bioinf., 2007, 66, 399-421.</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_Bydu2Qc">An effective docking strategy for virtual screening based on multi-objective optimization algorithm</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4wFsmmW">BMC Bioinf</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">58</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">H. Li, H. Zhang, M. Zheng, J. Luo, L. Kang, X. Liu, X. Wang and H. Jiang, An effective docking strategy for virtual screening based on multi-objective optimization algorithm, BMC Bioinf., 2009, 10, 58.</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_XWUXhXd">Consensus Docking: Improving the Reliability of Docking in a Virtual Screening Context</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Houston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Walkinshaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PRbwb59">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="384" to="390" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. R. Houston and M. D. Walkinshaw, Consensus Docking: Improving the Reliability of Docking in a Virtual Screening Context, J. Chem. Inf. Model., 2013, 53, 384-390.</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main" xml:id="_gfKD4gn">Modock: A Multi-Objective Strategy Improves the Accuracy for Molecular Docking</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13015-015-0034-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7HYnz6t">Algorithms Mol. Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">8</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Gu, X. Yang, L. Kang, J. Wu and X. Wang, Modock: A Multi-Objective Strategy Improves the Accuracy for Molecular Docking, Algorithms Mol. Biol., 2015, 10, 8.</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main" xml:id="_NTttjyS">DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design</title>
		<author>
			<persName><forename type="first">M</forename><surname>García-Ortegón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N C</forename><surname>Simm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Tripp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Hernández-Lobato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bacallado</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nb3ep5z">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="3486" to="3502" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. García-Ortegón, G. N. C. Simm, A. J. Tripp, J. M. Hernández-Lobato, A. Bender and S. Bacallado, DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design, J. Chem. Inf. Model., 2022, 62, 3486-3502.</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main" xml:id="_QBKGkep">Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Loiseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ingallinesi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Millan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Fone</surname></persName>
		</author>
		<idno type="DOI">10.1038/npp.2011.254</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_96crwsC">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="770" to="786" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. J. Watson, F. Loiseau, M. Ingallinesi, M. J. Millan, C. A. Marsden and K. C. Fone, Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex, Neuropsychopharmacology, 2012, 37, 770-786.</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main" xml:id="_w4RrhtV">Novel Dopamine Receptor 3 Antagonists Inhibit the Growth of Primary and Temozolomide Resistant Glioblastoma Cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Williford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ayokanmbi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Otamias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Gordillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Redmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Griguer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Napierala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ananthan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Hjelmeland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ud9QHHp">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">250649</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">S. E. Williford, C. J. Libby, A. Ayokanmbi, A. Otamias, J. J. Gordillo, E. R. Gordon, S. J. Cooper, M. Redmann, Y. Li, C. Griguer, J. Zhang, M. Napierala, S. Ananthan and A. B. Hjelmeland, Novel Dopamine Receptor 3 Antagonists Inhibit the Growth of Primary and Temozolomide Resistant Glioblastoma Cells, PLoS ONE, 2021, 16, e0250649.</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_5z4327F">Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and m-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bonifazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Saab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Nazarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Zaidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jahan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Katritch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Canals</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Newman</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jmedchem.3c00417</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HQaeQTw">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="10304" to="10341" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Bonifazi, E. Saab, J. Sanchez, A. L. Nazarova, S. A. Zaidi, K. Jahan, V. Katritch, M. Canals, J. R. Lane and A. H. Newman, Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D3 (D3R) and m-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics, J. Med. Chem., 2023, 66(15), 10304-10341.</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_sgExUXK">Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Fridman</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0902819</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vcQCGrZ">J. Immunol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="5298" to="5307" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. S. Fridman, et al., Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050, J. Immunol., 2010, 184, 5298-5307.</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main" xml:id="_WqNV97g">Design and Synthesis of Carbazole Carboxamides as Promising Inhibitors of Bruton&apos;s Tyrosine Kinase (BTK) and Janus Kinase 2 (JAK2)</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Batt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Lippy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Surti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Tebben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Muckelbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pokross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Tino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PyPGczq">Bioorg. Med. Chem. Lett</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="4265" to="4269" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Q. Liu, D. G. Batt, J. S. Lippy, N. Surti, A. J. Tebben, J. K. Muckelbauer, L. Chen, Y. An, C. Chang, M. Pokross, Z. Yang, H. Wang, J. R. Burke, P. H. Carter and J. A. Tino, Design and Synthesis of Carbazole Carboxamides as Promising Inhibitors of Bruton&apos;s Tyrosine Kinase (BTK) and Janus Kinase 2 (JAK2), Bioorg. Med. Chem. Lett., 2015, 25, 4265-4269.</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_GQuCHZD">Inhibition of the Insulinlike Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach</title>
		<author>
			<persName><forename type="first">R</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pourpak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Morris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vPQykz6">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="4981" to="5004" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. Li, A. Pourpak and S. W. Morris, Inhibition of the Insulin- like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach, J. Med. Chem., 2009, 52, 4981-5004.</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_bQSHu5V">3D QSAR and Pharmacophore Studies on Inhibitors of Insuline Like Growth Factor 1 Receptor (IGF-1R) and Insulin Receptor (IR) as Potential Anti-Cancer Agents</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Pasha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jabeen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Samarasinghe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.crchbi.2022.100019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YjXSNnM">Curr. Res. Chem. Biol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">100019</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. K. Pasha, I. Jabeen and S. Samarasinghe, 3D QSAR and Pharmacophore Studies on Inhibitors of Insuline Like Growth Factor 1 Receptor (IGF-1R) and Insulin Receptor (IR) as Potential Anti-Cancer Agents, Curr. Res. Chem. Biol., 2022, 2, 100019.</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_FK2Mv3s">Imidazole Moiety Replacements in the 3-(1H-Benzo[d]imidazol-2-Yl)pyridin-2(1H)-One Inhibitors of Insulin-Like Growth Factor Receptor-1 (IGF-1R) to Improve Cytochrome P450 Prole</title>
		<author>
			<persName><forename type="first">U</forename><surname>Velaparthi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Balasubramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carboni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Attar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gottardis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Greer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zoeckler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wittman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vyas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sdyKDQb">Bioorg. Med. Chem. Lett</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="3072" to="3076" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">U. Velaparthi, P. Liu, B. Balasubramanian, J. Carboni, R. Attar, M. Gottardis, A. Li, A. Greer, M. Zoeckler, M. D. Wittman and D. Vyas, Imidazole Moiety Replacements in the 3-(1H-Benzo[d]imidazol-2-Yl)pyridin- 2(1H)-One Inhibitors of Insulin-Like Growth Factor Receptor-1 (IGF-1R) to Improve Cytochrome P450 Prole, Bioorg. Med. Chem. Lett., 2007, 17, 3072-3076.</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_3qJxDsj">Balancing Oral Exposure with CYP3A4 Inhibition in Benzimidazole-Based IGF-IR Inhibitors</title>
		<author>
			<persName><forename type="first">K</forename><surname>Zimmermann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bmcl.2008.05.104</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tF4CmnS">Bioorg. Med. Chem. Lett</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="4075" to="4080" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Zimmermann, et al., Balancing Oral Exposure with CYP3A4 Inhibition in Benzimidazole-Based IGF-IR Inhibitors, Bioorg. Med. Chem. Lett., 2008, 18, 4075-4080.</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main" xml:id="_bHwF5Qj">Inhibition and Induction of Cytochrome P450 and the Clinical Implications</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y H</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.2165/00003088-199835050-00003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_89uAWdd">Clin. Pharmacokinet</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="361" to="390" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. H. Lin and A. Y. H. Lu, Inhibition and Induction of Cytochrome P450 and the Clinical Implications, Clin. Pharmacokinet., 1998, 35, 361-390.</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_WdvdGeY">The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse Effects</title>
		<author>
			<persName><forename type="first">T</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Price</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8tSE2CJ">Am. Fam. Physician</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="391" to="396" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">T. Lynch and A. Price, The Effect of Cytochrome P450 Metabolism on Drug Response, Interactions, and Adverse Effects, Am. Fam. Physician, 2007, 76, 391-396.</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main" xml:id="_Sjt4Txy">Insights into Molecular Basis of Cytochrome P450 Inhibitory Promiscuity of Compounds</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Dwj74Dj">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="2482" to="2495" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Cheng, Y. Yu, Y. Zhou, Z. Shen, W. Xiao, G. Liu, W. Li, P. W. Lee and Y. Tang, Insights into Molecular Basis of Cytochrome P450 Inhibitory Promiscuity of Compounds, J. Chem. Inf. Model., 2011, 51, 2482-2495.</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main" xml:id="_RD56GRh">Analyzing Learned Molecular Representations for Property Prediction</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Swanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Coley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Eiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Guzman-Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hopper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kelley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mathea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Settels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jaakkola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barzilay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sgzphNE">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="3370" to="3388" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">K. Yang, K. Swanson, W. Jin, C. Coley, P. Eiden, H. Gao, A. Guzman-Perez, T. Hopper, B. Kelley, M. Mathea, A. Palmer, V. Settels, T. Jaakkola, K. Jensen and R. Barzilay, Analyzing Learned Molecular Representations for Property Prediction, J. Chem. Inf. Model., 2019, 59, 3370-3388.</note>
</biblStruct>

<biblStruct xml:id="b97">
	<monogr>
		<title level="m" type="main" xml:id="_Z4fcpF7">Chemprop: A Machine Learning Package for Chemical Property Prediction</title>
		<author>
			<persName><forename type="first">E</forename><surname>Heid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Greenman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Graff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Vermeire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mcgill</surname></persName>
		</author>
		<idno type="DOI">10.26434/chemrxiv-2023-3zcfl</idno>
		<ptr target="https://chemrxiv.org/engage/chemrxiv/article-details/64d1f13d4a3f7d0c0dcd836b" />
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
	<note type="raw_reference">E. Heid, K. P. Greenman, Y. Chung, S.-C. Li, D. E. Graff, F. H. Vermeire, H. Wu, W. H. Green and C. J. McGill, Chemprop: A Machine Learning Package for Chemical Property Prediction, 2023, https://chemrxiv.org/engage/ chemrxiv/article-details/64d1f13d4a3f7d0c0dcd836b.</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_XhfWunf">A Practical Guide to Large-Scale Docking</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gahbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luttens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Fink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Balius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Irwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41596-021-00597-z</idno>
		<idno>100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_faFFn8n">Nat. Protoc</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="4799" to="4832" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">B. J. Bender, S. Gahbauer, A. Luttens, J. Lyu, C. M. Webb, R. M. Stein, E. A. Fink, T. E. Balius, J. Carlsson, J. J. Irwin and B. K. Shoichet, A Practical Guide to Large-Scale Docking, Nat. Protoc., 2021, 16, 4799-4832. 100</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_yKhFg4u">The Properties of Known Drugs. 1. Molecular Frameworks</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Bemis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Murcko</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm9602928</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d2bfMCS">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">G. W. Bemis and M. A. Murcko, The Properties of Known Drugs. 1. Molecular Frameworks, J. Med. Chem., 1996, 39, 2887-2893. 101</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_MwDJnb2">UMAP: Uniform Manifold Approximation and Projection (version 0.5.4)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Mcinnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Healy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Saul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Großberger</surname></persName>
		</author>
		<idno type="DOI">10.21105/joss.00861</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g8MPvvK">J. Open Source Sow</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="861" to="102" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. McInnes, J. Healy, N. Saul and L. Großberger, UMAP: Uniform Manifold Approximation and Projection (version 0.5.4), J. Open Source Sow., 2018, 3, 861. 102</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_pktmtps">RBx10080307, a Dual EGFR/IGF-1R Inhibitor for Anticancer Therapy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tandon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2013.04.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QdpJ4xh">Eur. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">711</biblScope>
			<biblScope unit="page">103</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. Tandon, et al., RBx10080307, a Dual EGFR/IGF-1R Inhibitor for Anticancer Therapy, Eur. J. Pharmacol., 2013, 711, 19-26. 103</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main" xml:id="_2G2tbhe">Dual Target Inhibitors Based on EGFR: Promising Anticancer Agents for the Treatment of Cancers (2017-)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Qi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejmech.2021.113963</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yunq3c9">Eur. J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">227</biblScope>
			<biblScope unit="page" from="113963" to="113104" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. Hu, M. Fan, S. Shi, X. Song, F. Wang, H. He and B. Qi, Dual Target Inhibitors Based on EGFR: Promising Anticancer Agents for the Treatment of Cancers (2017-), Eur. J. Med. Chem., 2022, 227, 113963. 104</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_BfM3MTS">Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Fzr5gKN">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="10382" to="10105" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">J. Kang, Z. Guo, H. Zhang, R. Guo, X. Zhu and X. Guo, Dual Inhibition of EGFR and IGF-1R Signaling Leads to Enhanced Antitumor Efficacy against Esophageal Squamous Cancer, Int. J. Mol. Sci., 2022, 23, 10382. 105</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_cJYHbpA">Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A S</forename><surname>Abourehab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Alqahtani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G M</forename><surname>Youssif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gouda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2HmNdhv">Molecules</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="6677" to="6106" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. A. S. Abourehab, A. M. Alqahtani, B. G. M. Youssif and A. M. Gouda, Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism, Molecules, 2021, 26, 6677. 106</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main" xml:id="_nWhPTH7">Consideration of molecular weight during compound selection in virtual target-based database screening</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mackerell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_p4WAgZR">J. Chem. Inf. Comput. Sci</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="267" to="272" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Pan, N. Huang, S. Cho and A. D. MacKerell, Consideration of molecular weight during compound selection in virtual target-based database screening, J. Chem. Inf. Comput. Sci., 2003, 43, 267-272.</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main" xml:id="_ThGcJNA">BatchBALD: Efficient and Diverse Batch Acquisition for Deep Bayesian Active Learning</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Amersfoort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_EHAmH3F">Advances in Neural Information Processing Systems</title>
		<imprint>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page">108</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Kirsch, J. van Amersfoort and Y. Gal, BatchBALD: Efficient and Diverse Batch Acquisition for Deep Bayesian Active Learning, Advances in Neural Information Processing Systems, 2019. 108</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main" xml:id="_YswwqkF">Rational Approaches to Improving Selectivity in Drug Design</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Huggins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sherman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tidor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RrnFwjD">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page">109</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D. J. Huggins, W. Sherman and B. Tidor, Rational Approaches to Improving Selectivity in Drug Design, J. Med. Chem., 2012, 55, 1424-1444. 109</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main" xml:id="_H3PU6pB">GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR-Mediated Side Effects</title>
		<author>
			<persName><forename type="first">T</forename><surname>Klabunde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Evers</surname></persName>
		</author>
		<ptr target="http://www.rdkit.org/.111" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_Fap7Yqq">Source Cheminformatics Soware</title>
		<imprint>
			<date type="published" when="2005">2005. 2021</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="876" to="889" />
		</imprint>
	</monogr>
	<note>RDKit</note>
	<note type="raw_reference">T. Klabunde and A. Evers, GPCR Antitarget Modeling: Pharmacophore Models for Biogenic Amine Binding GPCRs to Avoid GPCR-Mediated Side Effects, ChemBioChem, 2005, 6, 876-889. 110 RDKit, Open-Source Cheminformatics Soware(version 2021.03.3), http://www.rdkit.org/. 111</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main" xml:id="_vauSMsU">Bayesian Optimization Package: PHYSBO</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Motoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshimi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Terayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TyuvZTg">Comput. Phys. Commun</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="108405" to="108112" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Y. Motoyama, R. Tamura, K. Yoshimi, K. Terayama, T. Ueno and K. Tsuda, Bayesian Optimization Package: PHYSBO, Comput. Phys. Commun., 2022, 278, 108405. 112</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main" xml:id="_aAFnNUp">Fast Calculation of Multiobjective Probability of Improvement and Expected Improvement Criteria for Pareto Optimization</title>
		<author>
			<persName><forename type="first">I</forename><surname>Couckuyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Deschrijver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dhaene</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_r7mtReB">J. Global Optim</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">I. Couckuyt, D. Deschrijver and T. Dhaene, Fast Calculation of Multiobjective Probability of Improvement and Expected Improvement Criteria for Pareto Optimization, J. Global Optim., 2014, 60, 575-594. 113</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main" xml:id="_jaad8pU">A Parallel Global Multiobjective Framework for Optimization: Pagmo (version 2.19.5)</title>
		<author>
			<persName><forename type="first">F</forename><surname>Biscani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Izzo</surname></persName>
		</author>
		<idno type="DOI">10.21105/joss.02338</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EnpyGbD">J. Open Source Sow</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="2338" to="2114" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Biscani and D. Izzo, A Parallel Global Multiobjective Framework for Optimization: Pagmo (version 2.19.5), J. Open Source Sow., 2020, 5, 2338. 114</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main" xml:id="_nGxnxaP">PyTorch: An Imperative Style, High-Performance Deep Learning Library (version 1.13</title>
		<author>
			<persName><forename type="first">A</forename><surname>Paszke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_5BxsUD9">Advances in Neural Information Processing Systems</title>
		<imprint>
			<date type="published" when="2019">2019</date>
			<biblScope unit="page">115</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Paszke and et al., PyTorch: An Imperative Style, High- Performance Deep Learning Library (version 1.13.1), Advances in Neural Information Processing Systems, 2019. 115</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main" xml:id="_Pc8pyzw">Estimating the Mean and Variance of the Target Probability Distribution</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weigend</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_PG8QcmK">Proceedings of 1994 IEEE International Conference on Neural Networks</title>
		<meeting>1994 IEEE International Conference on Neural Networks</meeting>
		<imprint>
			<date type="published" when="1994">1994</date>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">116</biblScope>
		</imprint>
	</monogr>
	<note>ICNN&apos;94</note>
	<note type="raw_reference">D. Nix and A. Weigend, Estimating the Mean and Variance of the Target Probability Distribution, Proceedings of 1994 IEEE International Conference on Neural Networks, (ICNN&apos;94), 1994, vol. 1, pp. 55-60. 116</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main" xml:id="_S6strF5">Uncertainty Quantication Using Neural Networks for Molecular Property Prediction</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hirschfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Swanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Barzilay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Coley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v47zxwR">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="3770" to="3780" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">L. Hirschfeld, K. Swanson, K. Yang, R. Barzilay and C. W. Coley, Uncertainty Quantication Using Neural Networks for Molecular Property Prediction, J. Chem. Inf. Model., 2020, 60, 3770-3780.</note>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main" xml:id="_kPsWeMh">Atom Pairs as Molecular Features in Structure-Activity Studies: Denition and Applications</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Carhart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Venkataraghavan</surname></persName>
		</author>
		<idno type="DOI">10.1021/ci00046a002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m5hHjDQ">J. Chem. Inf. Comput. Sci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page">118</biblScope>
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. E. Carhart, D. H. Smith and R. Venkataraghavan, Atom Pairs as Molecular Features in Structure-Activity Studies: Denition and Applications, J. Chem. Inf. Comput. Sci., 1985, 25, 64-73. 118</note>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main" xml:id="_2pEpmwq">Atom Pair 2D-Fingerprints Perceive 3D-Molecular Shape and Pharmacophores for Very Fast Virtual Screening of ZINC and GDB-17</title>
		<author>
			<persName><forename type="first">M</forename><surname>Awale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-L</forename><surname>Reymond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2f65KVD">J. Chem. Inf. Model</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page">119</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">M. Awale and J.-L. Reymond, Atom Pair 2D-Fingerprints Perceive 3D-Molecular Shape and Pharmacophores for Very Fast Virtual Screening of ZINC and GDB-17, J. Chem. Inf. Model., 2014, 54, 1892-1907. 119</note>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main" xml:id="_Bg5g8tr">Comparing structural ngerprints using a literature-based similarity benchmark</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>O'boyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Sayle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9pa9fmG">J. Cheminf</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="36" to="120" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">N. M. O&apos;Boyle and R. A. Sayle, Comparing structural ngerprints using a literature-based similarity benchmark, J. Cheminf., 2016, 8, 36. 120</note>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main" xml:id="_nAJGdzk">Web-Scale k-Means Clustering</title>
		<author>
			<persName><forename type="first">D</forename><surname>Sculley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_dq4v98t">Proceedings of the 19th international conference on World wide web</title>
		<meeting>the 19th international conference on World wide web<address><addrLine>Raleigh North Carolina USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="page">121</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">D. Sculley, Web-Scale k-Means Clustering, Proceedings of the 19th international conference on World wide web, Raleigh North Carolina USA, 2010, pp. 1177-1178. 121</note>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main" xml:id="_6eXYvw4">Scikit-learn: Machine Learning in Python (version 1.3.2)</title>
		<author>
			<persName><forename type="first">F</forename><surname>Pedregosa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HYBj23D">J. Mach. Learn. Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">122</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">F. Pedregosa, et al., Scikit-learn: Machine Learning in Python (version 1.3.2), J. Mach. Learn. Res., 2011, 12, 2825-2830. 122</note>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main" xml:id="_FPaABxM">An Analysis of Quality Indicators Using Approximated Optimal Distributions in a 3-D Objective Space</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishibuchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Pt7dmWJ">IEEE Trans. Evol. Comput</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="853" to="867" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">R. Tanabe and H. Ishibuchi, An Analysis of Quality Indicators Using Approximated Optimal Distributions in a 3-D Objective Space, IEEE Trans. Evol. Comput., 2020, 24, 853-867.</note>
</biblStruct>

<biblStruct xml:id="b121">
	<monogr>
		<author>
			<persName><forename type="first">A</forename><surname>Reuther</surname></persName>
		</author>
		<title level="m" xml:id="_jGD6KXJ">Interactive Supercomputing on 40,000 Cores for Machine Learning and Data Analysis</title>
		<imprint>
			<date type="published" when="2018">2018. 2018</date>
			<biblScope unit="page" from="1" to="6" />
		</imprint>
	</monogr>
	<note>IEEE High Performance extreme Computing Conference (HPEC)</note>
	<note type="raw_reference">A. Reuther and et al., Interactive Supercomputing on 40,000 Cores for Machine Learning and Data Analysis, 2018 IEEE High Performance extreme Computing Conference (HPEC), 2018, pp. 1-6.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
